Revised. Amendments from Version 2
==================================

We have fixed bugs in the workflow code that were introduced with changes to the arguments required by the \"cpg.annotate\" and \"DMR.plot\" functions in the *DMRcate* package. Figure 11 once again shows the top ranked DMR, as in version 1 of the workflow. A bug present in the *minfi* \"preprocessQuantile\" function during the generation of version 2 necessitated us to plot DMR 11 in order to show all of the features we were trying to display; this has now been fixed by the *minfi* authors. We have changed the links to the data on figshare to a modified version of the dataset which now includes CpG islands and DNAse I hypersensitive sites for chr17 instead of chr22, to reflect the change to the DMR that is being shown in Figure 11. We have also included a link to a live (as opposed to static) version of this workflow on the Bioconductor website.

Introduction
============

DNA methylation, the addition of a methyl group to a CG dinucleotide of the DNA, is the most extensively studied epigenetic mark due to its role in both development and disease ( [@ref-6]; [@ref-20]). Although DNA methylation can be measured in several ways, the epigenetics community has enthusiastically embraced the Illumina HumanMethylation450 (450k) array ( [@ref-4]) as a cost-effective way to assay methylation across the human genome. More recently, Illumina has increased the genomic coverage of the platform to \>850,000 sites with the release of their MethylationEPIC (850k) array. As methylation arrays are likely to remain popular for measuring methylation for the foreseeable future, it is necessary to provide robust workflows for methylation array analysis.

Measurement of DNA methylation by Infinium technology (Infinium I) was first employed by Illumina on the HumanMethylation27 (27k) array ( [@ref-5]), which measured methylation at approximately 27,000 CpGs, primarily in gene promoters. Like bisulfite sequencing, the Infinium assay detects methylation status at single base resolution. However, due to its relatively limited coverage the array platform was not truly considered "genome-wide" until the arrival of the 450k array. The 450k array increased the genomic coverage of the platform to over 450,000 gene-centric sites by combining the original Infinium I assay with the novel Infinium II probes. Both assay types employ 50bp probes that query a \[C/T\] polymorphism created by bisulfite conversion of unmethylated cytosines in the genome, however, the Infinium I and II assays differ in the number of beads required to detect methylation at a single locus. Infinium I uses two bead types per CpG, one for each of the methylated and unmethylated states ( [Figure 1a](#f1){ref-type="fig"}). In contrast, the Infinium II design uses one bead type and the methylated state is determined at the single base extension step after hybridization ( [Figure 1b](#f1){ref-type="fig"}). The 850k array also uses a combination of the Infinium I and II assays but achieves additional coverage by increasing the size of each array; a 450k slide contains 12 arrays whilst the 850k has only 8.

Regardless of the Illumina array version, for each CpG, there are two measurements: a methylated intensity (denoted by *M*) and an unmethylated intensity (denoted by *U*). These intensity values can be used to determine the proportion of methylation at each CpG locus. Methylation levels are commonly reported as either beta values ( *β* = *M/*( *M* + *U*)) or M-values ( *M value* = *log*2( *M/U*)). For practical purposes, a small offset, *α*, can be added to the denominator of the *β* value equation to avoid dividing by small values, which is the default behaviour of the `getBeta` function in *minfi*. The default value for *α* is 100. It may also be desirable to add a small offset to the numerator and denominator when calculating M-values to avoid dividing by zero in rare cases, however the default `getM` function in *minfi* does not do this. Beta values and M-values are related through a logit transformation. Beta values are generally preferable for describing the level of methylation at a locus or for graphical presentation because percentage methylation is easily interpretable. However, due to their distributional properties, M-values are more appropriate for statistical testing ( [@ref-10]).

In this workflow, we will provide examples of the steps involved in analysing methylation array data using R ( [@ref-31]) and Bioconductor ( [@ref-17]), including: quality control, filtering, normalisation, data exploration and probe-wise differential methylation analysis. We will also cover other approaches such as differential methylation analysis of regions, differential variability analysis, gene ontology analysis and estimating cell type composition. Finally, we will provide some examples of useful ways to visualise methylation array data.

Differential methylation analysis
=================================

Obtaining the data
------------------

All of the data used in this workflow can be downloaded and extracted in R using the `download.file` and `untar` functions, as shown below. Alternatively, the data can be manually downloaded from: <https://figshare.com/articles/methylAnalysisDataV3_tar_gz/4800970>.

\# the URL for the data download url \<- \"<https://ndownloader.figshare.com/files/7896205>\" *\# download the data* if(!file.exists(\"methylAnalysisDataV3.tar.gz\")){ download.file(url,destfile=\"methylAnalysisDataV3.tar.gz\"method=\"auto\") } *\# extract the data* if(!file.exists(\"./data\")){ untar(\"methylAnalysisDataV3.tar.gz\",exdir=\".\",compressed=\"gzip\") }

Once the data has been downloaded and extracted, there should be a folder called `data` that contains all the files necessary to execute the workflow.

![Illumina Infinium HumanMethylation450 assay, reproduced from [@ref-24].\
( **a**) Infinium I assay. Each individual CpG is interrogated using two bead types: methylated (M) and unmethylated (U). Both bead types will incorporate the same labeled nucleotide for the same target CpG, thereby producing the same color fluorescence. The nucleotide that is added is determined by the base downstream of the "C" of the target CpG. The proportion of methylation can be calculated by comparing the intensities from the two different probes in the same color. ( **b**) Infinium II assay. Each target CpG is interrogated using a single bead type. Methylation state is detected by single base extension at the position of the "C" of the target CpG, which always results in the addition of a labeled "G" or "A" nucleotide, complementary to either the "methylated" C or "unmethylated" T, respectively. Each locus is detected in two colors, and methylation status is determined by comparing the two colors from the one position.](f1000research-5-12222-g0000){#f1}

\# set up a path to the data directory dataDirectory \<- \"./data\" \# list the files list.files (dataDirectory, recursive= TRUE )

\#\# \[1\] \"48639-non-specific-probes-Illumina450k.csv\" \#\# \[2\] \"5975827018/5975827018_R06C02_Grn.idat\" \#\# \[3\] \"5975827018/5975827018_R06C02_Red.idat\" \#\# \[4\] \"6264509100/6264509100_R01C01_Grn.idat\" \#\# \[5\] \"6264509100/6264509100_R01C01_Red.idat\" \#\# \[6\] \"6264509100/6264509100_R01C02_Grn.idat\" \#\# \[7\] \"6264509100/6264509100_R01C02_Red.idat\" \#\# \[8\] \"6264509100/6264509100_R02C01_Grn.idat\" \#\# \[9\] \"6264509100/6264509100_R02C01_Red.idat\" \#\# \[10\] \"6264509100/6264509100_R02C02_Grn.idat\" \#\# \[11\] \"6264509100/6264509100_R02C02_Red.idat\" \#\# \[12\] \"6264509100/6264509100_R03C01_Grn.idat\" \#\# \[13\] \"6264509100/6264509100_R03C01_Red.idat\" \#\# \[14\] \"6264509100/6264509100_R03C02_Grn.idat\" \#\# \[15\] \"6264509100/6264509100_R03C02_Red.idat\" \#\# \[16\] \"6264509100/6264509100_R04C01_Grn.idat\" \#\# \[17\] \"6264509100/6264509100_R04C01_Red.idat\" \#\# \[18\] \"6264509100/6264509100_R04C02_Grn.idat\" \#\# \[19\] \"6264509100/6264509100_R04C02_Red.idat\" \#\# \[20\] \"6264509100/6264509100_R05C01_Grn.idat\" \#\# \[21\] \"6264509100/6264509100_R05C01_Red.idat\" \#\# \[22\] \"6264509100/6264509100_R05C02_Grn.idat\" \#\# \[23\] \"6264509100/6264509100_R05C02_Red.idat\" \#\# \[24\] \"6264509100/6264509100_R06C01_Grn.idat\" \#\# \[25\] \"6264509100/6264509100_R06C01_Red.idat\" \#\# \[26\] \"6264509100/6264509100_R06C02_Grn.idat\" \#\# \[27\] \"6264509100/6264509100_R06C02_Red.idat\" \#\# \[28\] \"ageData.RData\" \#\# \[29\] \"human_c2_v5.rdata\" \#\# \[30\] \"model-based-cpg-islands-hg19-chr17.txt\" \#\# \[31\] \"SampleSheet.csv\" \#\# \[32\] \"wgEncodeRegDnaseClusteredV3chr17.bed\"

To demonstrate the various aspects of analysing methylation data, we will be using a small, publicly available 450k methylation dataset (GSE49667) ( [@ref-43]). The dataset contains 10 samples in total: there are 4 different sorted T-cell types (naive, rTreg, act_naive, act_rTreg, collected from 3 different individuals (M28, M29, M30). For details describing sample collection and preparation, see [@ref-43]. An additional `birth` sample (individual VICS-72098-18-B) is included from another study (GSE51180) ( [@ref-8]) to illustrate approaches for identifying and excluding poor quality samples.

There are several R Bioconductor packages available that have been developed for analysing methylation array data, including *minfi* ( [@ref-1]), *missMethyl* ( [@ref-28]), *wateRmelon* ( [@ref-30]), *methylumi* ( [@ref-9]), *ChAMP* ( [@ref-26]) and *charm* ( [@ref-2]). Some of the packages, such as *minfi* and *methylumi* include a framework for reading in the raw data from IDAT files and various specialised objects for storing and manipulating the data throughout the course of an analysis. Other packages provide specialised analysis methods for normalisation and statistical testing that rely on either *minfi* or *methylumi* objects. It is possible to convert between *minfi* and *methylumi* data types, however, this is not always trivial. Thus, it is advisable to consider the methods that you are interested in using and the data types that are most appropriate before you begin your analysis. Another popular method for analysing methylation array data is *limma* ( [@ref-32]), which was originally developed for gene expression microarray analysis. As *limma* operates on a matrix of values, it is easily applied to any data that can be converted to a `matrix` in R. For a complete list of Bioconductor packages for analysing DNA methylation data, one can search for "DNAMethylation" in BiocViews ( <https://www.bioconductor.org/packages/release/BiocViews.html#___DNAMethylation>) on the Bioconductor website.

We will begin with an example of a **probe-wise** differential methylation analysis using *minfi* and *limma*. By **probe-wise** analysis we mean each individual CpG probe will be tested for differential methylation for the comparisons of interest and p-values and moderated t-statistics ( [@ref-34]) will be generated for each CpG probe.

Loading the data
----------------

It is useful to begin an analysis in R by loading all the packages that are likely to be required.

\# load packages required for analysis library (limma) library (minfi) library (IlluminaHumanMethylation450kanno.ilmn12.hg19) library (IlluminaHumanMethylation450kmanifest) library (RColorBrewer) library (missMethyl) library (matrixStats) library (minfiData) library (Gviz) library (DMRcate) library (stringr)

The *minfi*, *IlluminaHumanMethylation450kanno.ilmn12.hg19*, *IlluminaHumanMethylation450kmanifest*, *missMethyl*, *minfiData* and *DMRcate* are methylation specific packages, while *RColorBrewer* and *Gviz* are visualisation packages. We use *limma* for testing differential methylation, and *matrixStats* and *stringr* have functions used in the workflow. The *IlluminaHumanMethylation450kmanifest* package provides the Illumina manifest as an R object which can easily be loaded into the environment. The manifest contains all of the annotation information for each of the CpG probes on the 450k array. This is useful for determining where any differentially methylated probes are located in a genomic context.

\# get the 450k annotation data ann450k = getAnnotation (IlluminaHumanMethylation450kanno.ilmn12.hg19) head(ann450k)

\#\# DataFrame with 6 rows and 33 columns \#\# chr pos strand Name AddressA \#\# \<character\> \<integer\> \<character\> \<character\> \<character\> \#\# cg00050873 chrY 9363356 - cg00050873 32735311 \#\# cg00212031 chrY 21239348 - cg00212031 29674443 \#\# cg00213748 chrY 8148233 - cg00213748 30703409 \#\# cg00214611 chrY 15815688 - cg00214611 69792329 \#\# cg00455876 chrY 9385539 - cg00455876 27653438 \#\# cg01707559 chrY 6778695 + cg01707559 45652402 \#\# AddressB ProbeSeqA \#\# \<character\> \<character\> \#\# cg00050873 31717405 ACAAAAAAACAACACACAACTATAATAATTTTTAAAATAAATAAACCCCA \#\# cg00212031 38703326 CCCAATTAACCACAAAAACTAAACAAATTATACAATCAAAAAAACATACA \#\# cg00213748 36767301 TTTTAACACCTAACACCATTTTAACAATAAAAATTCTACAAAAAAAAACA \#\# cg00214611 46723459 CTAACTTCCAAACCACACTTTATATACTAAACTACAATATAACACAAACA \#\# cg00455876 69732350 AACTCTAAACTACCCAACACAAACTCCAAAAACTTCTCAAAAAAAACTCA \#\# cg01707559 64689504 ACAAATTAAAAACACTAAAACAAACACAACAACTACAACAACAAAAAACA \#\# ProbeSeqB Type \#\# \<character\> \<character\> \#\# cg00050873 ACGAAAAAACAACGCACAACTATAATAATTTTTAAAATAAATAAACCCCG I \#\# cg00212031 CCCAATTAACCGCAAAAACTAAACAAATTATACGATCGAAAAAACGTACG I \#\# cg00213748 TTTTAACGCCTAACACCGTTTTAACGATAAAAATTCTACAAAAAAAAACG I \#\# cg00214611 CTAACTTCCGAACCGCGCTTTATATACTAAACTACAATATAACGCGAACG I \#\# cg00455876 AACTCTAAACTACCCGACACAAACTCCAAAAACTTCTCGAAAAAAACTCG I \#\# cg01707559 GCGAATTAAAAACACTAAAACGAACGCGACGACTACAACGACAAAAAACG I \#\# NextBase Color Probe_rs Probe_maf CpG_rs \#\# \<character\> \<character\> \<character\> \<numeric\> \<character\> \#\# cg00050873 A Red NA NA NA \#\# cg00212031 T Red NA NA NA \#\# cg00213748 A Red NA NA NA \#\# cg00214611 A Red NA NA NA \#\# cg00455876 A Red NA NA NA \#\# cg01707559 A Red NA NA NA \#\# CpG_maf SBE_rs SBE_maf Islands_Name \#\# \<numeric\> \<character\> \<numeric\> \<character\> \#\# cg00050873 NA NA NA chrY:9363680-9363943 \#\# cg00212031 NA NA NA chrY:21238448-21240005 \#\# cg00213748 NA NA NA chrY:8147877-8148210 \#\# cg00214611 NA NA NA chrY:15815488-15815779 \#\# cg00455876 NA NA NA chrY:9385471-9385777 \#\# cg01707559 NA NA NA chrY:6778574-6780028 \#\# Relation_to_Island \#\# \<character\> \#\# cg00050873 N_Shore \#\# cg00212031 Island \#\# cg00213748 S_Shore \#\# cg00214611 Island \#\# cg00455876 Island \#\# cg01707559 Island \#\# \#\# Forward_Sequence \#\# \<character\> \#\# cg00050873 TATCTCTGTCTGGCGAGGAGGCAACGCACAACTGTGGTGGTTTTTGGAGTGGGTGGACCC\[CG\] \#\# cg00212031 CCATTGGCCCGCCCCAGTTGGCCGCAGGGACTGAGCAAGTTATGCGGTCGGGAAGACGTG\[CG\] \#\# cg00213748 TCTGTGGGACCATTTTAACGCCTGGCACCGTTTTAACGATGGAGGTTCTGCAGGAGGGGG\[CG\] \#\# cg00214611 GCGCCGGCAGGACTAGCTTCCGGGCCGCGCTTTGTGTGCTGGGCTGCAGTGTGGCGCGGG\[CG\] \#\# cg00455876 CGCGTGTGCCTGGACTCTGAGCTACCCGGCACAAGCTCCAAGGGCTTCTCGGAGGAGGCT\[CG\] \#\# cg01707559 AGCGGCCGCTCCCAGTGGTGGTCACCGCCAGTGCCAATCCCTTGCGCCGCCGTGCAGTCC\[CG\] \#\# SourceSeq Random_Loci \#\# \<character\> \<character\> \#\# cg00050873 CGGGGTCCACCCACTCCAAAAACCACCACAGTTGTGCGTTGCCTCCTCGC \#\# cg00212031 CGCACGTCTTCCCGACCGCATAACTTGCTCAGTCCCTGCGGCCAACTGGG \#\# cg00213748 CGCCCCCTCCTGCAGAACCTCCATCGTTAAAACGGTGCCAGGCGTTAAAA \#\# cg00214611 CGCCCGCGCCACACTGCAGCCCAGCACACAAAGCGCGGCCCGGAAGCTAG \#\# cg00455876 GACTCTGAGCTACCCGGCACAAGCTCCAAGGGCTTCTCGGAGGAGGCTCG \#\# cg01707559 CGCCCTCTGTCGCTGCAGCCGCCGCGCCCGCTCCAGTGCCCCCAATTCGC \#\# Methyl27_Loci UCSC_RefGene_Name UCSC_RefGene_Accession \#\# \<character\> \<character\> \<character\> \#\# cg00050873 TSPY4;FAM197Y2 NM_001164471;NR_001553 \#\# cg00212031 TTTY14 NR_001543 \#\# cg00213748 \#\# cg00214611 TMSB4Y;TMSB4Y NM_004202;NM_004202 \#\# cg00455876 \#\# cg01707559 TBL1Y;TBL1Y;TBL1Y NM_134259;NM_033284;NM_134258 \#\# UCSC_RefGene_Group Phantom DMR Enhancer \#\# \<character\> \<character\> \<character\> \<character\> \#\# cg00050873 Body;TSS1500 \#\# cg00212031 TSS200 \#\# cg00213748 \#\# cg00214611 1stExon;5\'UTR \#\# cg00455876 \#\# cg01707559 TSS200;TSS200;TSS200 \#\# HMM_Island Regulatory_Feature_Name \#\# \<character\> \<character\> \#\# cg00050873 Y:9973136-9976273 \#\# cg00212031 Y:19697854-19699393 \#\# cg00213748 Y:8207555-8208234 \#\# cg00214611 Y:14324883-14325218 Y:15815422-15815706 \#\# cg00455876 Y:9993394-9995882 \#\# cg01707559 Y:6838022-6839951 \#\# Regulatory_Feature_Group DHS \#\# \<character\> \<character\> \#\# cg00050873 \#\# cg00212031 \#\# cg00213748 \#\# cg00214611 Promoter_Associated_Cell_type_specific \#\# cg00455876 \#\# cg01707559

As for their many other BeadArray platforms, Illumina methylation data is usually obtained in the form of Intensity Data (IDAT) Files. This is a proprietary format that is output by the scanner and stores summary intensities for each probe on the array. However, there are Bioconductor packages available that facilitate the import of data from IDAT files into R ( [@ref-33]). Typically, each IDAT file is approximately 8MB in size. The simplest way to import the raw methylation data into R is using the *minfi* function `read.metharray.sheet`, along with the path to the IDAT files and a sample sheet. The sample sheet is a CSV (comma-separated) file containing one line per sample, with a number of columns describing each sample. The format expected by the `read.metharray.sheet` function is based on the sample sheet file that usually accompanies Illumina methylation array data. It is also very similar to the targets file described by the *limma* package. Importing the sample sheet into R creates a `data.frame` with one row for each sample and several columns. The `read.metharray.sheet` function uses the specified path and other information from the sample sheet to create a column called `Basename` which specifies the location of each individual IDAT file in the experiment.

\# read in the sample sheet for the experiment targets \<- read.metharray.sheet (dataDirectory, pattern= \"SampleSheet.csv\" )

\#\# \[read.metharray.sheet\] Found the following CSV files: \#\# \[1\] \"./data/SampleSheet.csv\"

targets

\#\# Sample_Name Sample_Well Sample_Source Sample_Group Sample_Label \#\# 1 1 A1 M28 naive naive \#\# 2 2 B1 M28 rTreg rTreg \#\# 3 3 C1 M28 act_naive act_naive \#\# 4 4 D1 M29 naive naive \#\# 5 5 E1 M29 act_naive act_naive \#\# 6 6 F1 M29 act_rTreg act_rTreg \#\# 7 7 G1 M30 naive naive \#\# 8 8 H1 M30 rTreg rTreg \#\# 9 9 A2 M30 act_naive act_naive \#\# 10 10 B2 M30 act_rTreg act_rTreg \#\# 11 11 H06 VICS-72098-18-B birth birth \#\# Pool_ID Array Slide Basename \#\# 1 \<NA\> R01C01 6264509100 ./data/6264509100/6264509100_R01C01 \#\# 2 \<NA\> R02C01 6264509100 ./data/6264509100/6264509100_R02C01 \#\# 3 \<NA\> R03C01 6264509100 ./data/6264509100/6264509100_R03C01 \#\# 4 \<NA\> R04C01 6264509100 ./data/6264509100/6264509100_R04C01 \#\# 5 \<NA\> R05C01 6264509100 ./data/6264509100/6264509100_R05C01 \#\# 6 \<NA\> R06C01 6264509100 ./data/6264509100/6264509100_R06C01 \#\# 7 \<NA\> R01C02 6264509100 ./data/6264509100/6264509100_R01C02 \#\# 8 \<NA\> R02C02 6264509100 ./data/6264509100/6264509100_R02C02 \#\# 9 \<NA\> R03C02 6264509100 ./data/6264509100/6264509100_R03C02 \#\# 10 \<NA\> R04C02 6264509100 ./data/6264509100/6264509100_R04C02 \#\# 11 \<NA\> R06C02 5975827018 ./data/5975827018/5975827018_R06C02

Now that we have imported the information about the samples and where the data is located, we can read the raw intensity signals into R from the IDAT files using the `read.metharray.exp` function. This creates an `RGChannelSet` object that contains all the raw intensity data, from both the red and green colour channels, for each of the samples. At this stage, it can be useful to rename the samples with more descriptive names.

\# read in the raw data from the IDAT files rgSet \<- read.metharray.exp( targets= targets) rgSet

\#\# RGChannelSet (storageMode: lockedEnvironment) \#\# assayData: 622399 features, 11 samples \#\# element names: Green, Red \#\# An object of class \'AnnotatedDataFrame\' \#\# sampleNames: 6264509100_R01C01 6264509100_R02C01 \... \#\# 5975827018_R06C02 (11 total) \#\# varLabels: Sample_Name Sample_Well \... filenames (10 total) \#\# varMetadata: labelDescription \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19

\# give the samples descriptive names targets\$ID \<- paste (targets\$Sample_Group,targets\$Sample_Name, sep= \".\" ) sampleNames (rgSet) \<- targets\$ID rgSet

\#\# RGChannelSet (storageMode: lockedEnvironment) \#\# assayData: 622399 features, 11 samples \#\# element names: Green, Red \#\# An object of class \'AnnotatedDataFrame\' \#\# sampleNames: naive.1 rTreg.2 \... birth.11 (11 total) \#\# varLabels: Sample_Name Sample_Well \... filenames (10 total) \#\# varMetadata: labelDescription \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19

Quality control
---------------

Once the data has been imported into R, we can evaluate its quality. Firstly, we need to calculate detection p-values. We can generate a detection p-value for every CpG in every sample, which is indicative of the quality of the signal. The method used by *minfi* to calculate detection p-values compares the total signal ( *M* + *U*) for each probe to the background signal level, which is estimated from the negative control probes. Very small p-values are indicative of a reliable signal whilst large p-values, for example \>0.01, generally indicate a poor quality signal.

Plotting the mean detection p-value for each sample allows us to gauge the general quality of the samples in terms of the overall signal reliability ( [Figure 2](#f2){ref-type="fig"}). Samples that have many failed probes will have relatively large mean detection p-values.

\# calculate the detection p-values detP \<- detectionP (rgSet) head (detP)

\#\# naive.1 rTreg.2 act_naive.3 naive.4 act_naive.5 act_rTreg.6 \#\# cg00050873 0 0 0.000000e+00 0 0.00000e+00 0 \#\# cg00212031 0 0 0.000000e+00 0 0.00000e+00 0 \#\# cg00213748 0 0 1.181832e-12 0 8.21565e-15 0 \#\# cg00214611 0 0 0.000000e+00 0 0.00000e+00 0 \#\# cg00455876 0 0 0.000000e+00 0 0.00000e+00 0 \#\# cg01707559 0 0 0.000000e+00 0 0.00000e+00 0 \#\# naive.7 rTreg.8 act_naive.9 act_rTreg.10 birth.11 \#\# cg00050873 0 0.000000e+00 0 0.000000e+00 0.0000000 \#\# cg00212031 0 0.000000e+00 0 0.000000e+00 0.0000000 \#\# cg00213748 0 1.469801e-05 0 1.365951e-08 0.6735224 \#\# cg00214611 0 0.000000e+00 0 0.000000e+00 0.7344451 \#\# cg00455876 0 0.000000e+00 0 0.000000e+00 0.0000000 \#\# cg01707559 0 0.000000e+00 0 0.000000e+00 0.0000000

\# examine mean detection p-values across all samples to identify any failed samples pal \<- brewer.pal ( 8 , \"Dark2\" ) par ( mfrow=c ( 1 , 2 )) barplot ( colMeans (detP), col= pal\[ factor (targets\$Sample_Group)\], las= 2 , cex.names= 0.8 , ylab= \"Mean detection p-values\" ) abline ( h= 0.01 , col= \"red\" ) legend ( \"topleft\" , legend=levels ( factor (targets\$Sample_Group)), fill= pal, bg= \"white\" ) barplot ( colMeans (detP), col= pal\[ factor (targets\$Sample_Group)\], las= 2 , cex.names= 0.8 , ylim = c ( 0 , 0.002 ), ylab= \"Mean detection p-values\" ) legend ( \"topleft\" , legend=levels ( factor (targets\$Sample_Group)), fill= pal, bg= \"white\" )

![Mean detection p-values summarise the quality of the signal across all the probes in each sample.\
The plot on the right is a zoomed in version of the plot on the left.](f1000research-5-12222-g0001){#f2}

The *minfi* `qcReport` function generates many other useful quality control plots. The *minfi* vignette describes the various plots and how they should be interpreted in detail. Generally, samples that look poor based on mean detection p-value will also look poor using other metrics and it is usually advisable to exclude them from further analysis.

qcReport (rgSet, sampNames= targets\$ID, sampGroups= targets\$Sample_Group, pdf= \"qcReport.pdf\" )

Poor quality samples can be easily excluded from the analysis using a detection p-value cutoff, for example \>0.05. For this particular dataset, the `birth` sample shows a very high mean detection p-value, and hence it is excluded from subsequent analysis ( [Figure 2](#f2){ref-type="fig"}).

\# remove poor quality samples keep \<- colMeans (detP) \< 0.05 rgSet \<- rgSet\[,keep\] rgSet

\#\# RGChannelSet (storageMode: lockedEnvironment) \#\# assayData: 622399 features, 10 samples \#\# element names: Green, Red \#\# An object of class \'AnnotatedDataFrame\' \#\# sampleNames: naive.1 rTreg.2 \... act_rTreg.10 (10 total) \#\# varLabels: Sample_Name Sample_Well \... filenames (10 total) \#\# varMetadata: labelDescription \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19

\# remove poor quality samples from targets data targets \<- targets\[keep,\] targets\[, 1: 5 \]

\#\# Sample_Name Sample_Well Sample_Source Sample_Group Sample_Label \#\# 1 1 A1 M28 naive naive \#\# 2 2 B1 M28 rTreg rTreg \#\# 3 3 C1 M28 act_naive act_naive \#\# 4 4 D1 M29 naive naive \#\# 5 5 E1 M29 act_naive act_naive \#\# 6 6 F1 M29 act_rTreg act_rTreg \#\# 7 7 G1 M30 naive naive \#\# 8 8 H1 M30 rTreg rTreg \#\# 9 9 A2 M30 act_naive act_naive \#\# 10 10 B2 M30 act_rTreg act_rTreg

\# remove poor quality samples from detection p-value table detP \<- detP\[,keep\] dim (detP)

\#\# \[1\] 485512 10

Normalisation
-------------

To minimise the unwanted variation within and between samples, various data normalisations can be applied. Many different types of normalisation have been developed for methylation arrays and it is beyond the scope of this workflow to compare and contrast all of them ( [@ref-12]; [@ref-24]; [@ref-25]; [@ref-30]; [@ref-35]; [@ref-36]; [@ref-38]; [@ref-39]; [@ref-40]; [@ref-42]). Several methods have been built into *minfi* and can be directly applied within its framework ( [@ref-12]; [@ref-24]; [@ref-39]; [@ref-38]), whilst others are *methylumi*-specific or require custom data types ( [@ref-25]; [@ref-30]; [@ref-35]; [@ref-36]; [@ref-40]; [@ref-42]). Although there is no single normalisation method that is universally considered best, a recent study by [@ref-12] has suggested that a good rule of thumb within the *minfi* framework is that the `preprocessFunnorm` ( [@ref-12]) function is most appropriate for datasets with global methylation differences such as cancer/normal or vastly different tissue types, whilst the `preprocessQuantile` function ( [@ref-38]) is more suited for datasets where you do not expect global differences between your samples, for example a single tissue. Further discussion on appropriate choice of normalisation can be found in ( [@ref-15]), and the accompanying *quantro* package includes data-driven tests for the assumptions of quantile normalisation. As we are comparing different blood cell types, which are globally relatively similar, we will apply the `preprocessQuantile` method to our data ( [Figure 3](#f3){ref-type="fig"}). This function implements a stratified quantile normalisation procedure which is applied to the methylated and unmethylated signal intensities separately, and takes into account the different probe types. Note that after normalisation, the data is housed in a `GenomicRatioSet` object. This is a much more compact representation of the data as the colour channel information has been discarded and the *M* and *U* intensity information has been converted to M-values and beta values, together with associated genomic coordinates. Note, running the `preprocessQuantile` function on this dataset produces the warning: 'An inconsistency was encountered while determining sex'; this can be ignored as it is due to all the samples being from male donors.

\# normalize the data; this results in a GenomicRatioSet object mSetSq \<- preprocessQuantile (rgSet)

\#\# \[preprocessQuantile\] Mapping to genome. \#\# \[preprocessQuantile\] Fixing outliers. \#\# Warning in .getSex(CN = CN, xIndex = xIndex, yIndex = yIndex, cutoff \#\# = cutoff): An inconsistency was encountered while determining sex. One \#\# possibility is that only one sex is present. We recommend further checks, \#\# for example with the plotSex function. \#\# \[preprocessQuantile\] Quantile normalizing.

\# create a MethylSet object from the raw data for plotting mSetRaw \<- preprocessRaw (rgSet)

\# visualise what the data looks like before and after normalisation par ( mfrow=c ( 1 , 2 )) densityPlot (rgSet, sampGroups= targets\$Sample_Group, main= \"Raw\" , legend= FALSE ) legend ( \"top\" , legend = levels ( factor (targets\$Sample_Group)), text.col=brewer.pal ( 8 , \"Dark2\" )) densityPlot ( getBeta (mSetSq), sampGroups= targets\$Sample_Group, main= \"Normalized\" , legend= FALSE ) legend ( \"top\" , legend = levels ( factor (targets\$Sample_Group)), text.col=brewer.pal ( 8 , \"Dark2\" ))

![The density plots show the distribution of the beta values for each sample before and after normalisation.](f1000research-5-12222-g0002){#f3}

Data exploration
----------------

Multi-dimensional scaling (MDS) plots are excellent for visualising data, and are usually some of the first plots that should be made when exploring the data. MDS plots are based on principal components analysis and are an unsupervised method for looking at the similarities and differences between the various samples. Samples that are more similar to each other should cluster together, and samples that are very different should be further apart on the plot. Dimension one (or principal component one) captures the greatest source of variation in the data, dimension two captures the second greatest source of variation in the data and so on. Colouring the data points or labels by known factors of interest can often highlight exactly what the greatest sources of variation are in the data. It is also possible to use MDS plots to decipher sample mix-ups.

\# MDS plots to look at largest sources of variation par ( mfrow=c ( 1 , 2 )) plotMDS ( getM (mSetSq), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Group)\]) legend ( \"top\" , legend=levels ( factor (targets\$Sample_Group)), text.col= pal, bg= \"white\" , cex= 0.7 ) plotMDS ( getM (mSetSq), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Source)\]) legend ( \"top\" , legend=levels ( factor (targets\$Sample_Source)), text.col= pal, bg= \"white\" , cex= 0.7 )

Examining the MDS plots for this dataset demonstrates that the largest source of variation is the difference between individuals ( [Figure 4](#f4){ref-type="fig"}). The higher dimensions reveal that the differences between cell types are largely captured by the third and fourth principal components ( [Figure 5](#f5){ref-type="fig"}). This type of information is useful in that it can inform downstream analysis. If obvious sources of unwanted variation are revealed by the MDS plots, we can include them in our statistical model to account for them. In the case of this particular dataset, we will include individual to individual variation in our statistical model.

![Multi-dimensional scaling plots are a good way to visualise the relationships between the samples in an experiment.](f1000research-5-12222-g0003){#f4}

\# Examine higher dimensions to look at other sources of variation par ( mfrow=c ( 1 , 3 )) plotMDS ( getM (mSetSq), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Group)\], dim=c ( 1 , 3 )) legend ( \"top\" , legend=levels ( factor (targets\$Sample_Group)), text.col= pal, cex= 0.7 , bg= \"white\" ) plotMDS ( getM (mSetSq), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Group)\], dim=c ( 2 , 3 )) legend ( \"topleft\" , legend=levels ( factor (targets\$Sample_Group)), text.col= pal, cex= 0.7 , bg= \"white\" ) plotMDS ( getM (mSetSq), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Group)\], dim=c ( 3 , 4 )) legend ( \"topright\" , legend=levels ( factor (targets\$Sample_Group)), text.col= pal, cex= 0.7 , bg= \"white\" )

![Examining the higher dimensions of an MDS plot can reaveal significant sources of variation in the data.](f1000research-5-12222-g0004){#f5}

Filtering
---------

Poor performing probes are generally filtered out prior to differential methylation analysis. As the signal from these probes is unreliable, by removing them we perform fewer statistical tests and thus incur a reduced multiple testing penalty. We filter out probes that have failed in one or more samples based on detection p-value.

\# ensure probes are in the same order in the mSetSq and detP objects detP \<- detP\[ match ( featureNames (mSetSq), rownames (detP)),\] \# remove any probes that have failed in one or more samples keep \<- rowSums (detP \< 0.01 ) == ncol (mSetSq) table (keep)

\#\# keep \#\# FALSE TRUE \#\# 977 484535

mSetSqFlt \<- mSetSq\[keep,\] mSetSqFlt

\#\# class: GenomicRatioSet \#\# dim: 484535 10 \#\# metadata(0): \#\# assays(2): M CN \#\# rownames(484535): cg13869341 cg14008030 \... cg08265308 cg14273923 \#\# rowData names(0): \#\# colnames(10): naive.1 rTreg.2 \... act_naive.9 act_rTreg.10 \#\# colData names(11): Sample_Name Sample_Well \... filenames \#\# predictedSex \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19 \#\# Preprocessing \#\# Method: Raw (no normalization or bg correction) \#\# minfi version: 1.20.2 \#\# Manifest version: 0.4.0

Depending on the nature of your samples and your biological question you may also choose to filter out the probes from the X and Y chromosomes or probes that are known to have common SNPs at the CpG site. As the samples in this dataset were all derived from male donors, we will not be removing the sex chromosome probes as part of this analysis, however example code is provided below. A different dataset, which contains both male and female samples, is used to demonstrate a [Differential Variability](#DV){ref-type="other"} analysis and provides an example of when sex chromosome removal is necessary ( [Figure 13](#f13){ref-type="fig"}).

\# if your data includes males and females, remove probes on the sex chromosomes keep \<- !( featureNames (mSetSqFlt) %in% ann450k\$Name\[ann450k\$chr %in% c ( \"chrX\" , \"chrY\" )\]) table (keep) mSetSqFlt \<- mSetSqFlt\[keep,\]

There is a function in *minfi* that provides a simple interface for the removal of probes where common SNPs may affect the CpG. You can either remove all probes affected by SNPs (default), or only those with minor allele frequencies greater than a specified value.

\# remove probes with SNPs at CpG site mSetSqFlt \<- dropLociWithSnps (mSetSqFlt) mSetSqFlt

\#\# class: GenomicRatioSet \#\# dim: 467351 10 \#\# metadata(0): \#\# assays(2): M CN \#\# rownames(467351): cg13869341 cg14008030 \... cg08265308 cg14273923 \#\# rowData names(0): \#\# colnames(10): naive.1 rTreg.2 \... act_naive.9 act_rTreg.10 \#\# colData names(11): Sample_Name Sample_Well \... filenames \#\# predictedSex \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19 \#\# Preprocessing \#\# Method: Raw (no normalization or bg correction) \#\# minfi version: 1.20.2 \#\# Manifest version: 0.4.0

We will also filter out probes that have shown to be cross-reactive, that is, probes that have been demonstrated to map to multiple places in the genome. This list was originally published by [@ref-7] and can be obtained from the authors' [website](http://www.sickkids.ca/MS-Office-Files/Research/WeksbergLab/48639-non-specific-probes-Illumina450k.xlsx).

\# exclude cross reactive probes xReactiveProbes \<- read.csv ( file=paste (dataDirectory, \"48639-non-specific-probes-Illumina450k.csv\" , sep= \"/\" ), stringsAsFactors= FALSE ) keep \<- !( featureNames (mSetSqFlt) %in% xReactiveProbes\$TargetID) table (keep)

\#\# keep \#\# FALSE TRUE \#\# 27433 439918

mSetSqFlt \<- mSetSqFlt\[keep,\] mSetSqFlt

\#\# class: GenomicRatioSet \#\# dim: 439918 10 \#\# metadata(0): \#\# assays(2): M CN \#\# rownames(439918): cg13869341 cg24669183 \... cg08265308 cg14273923 \#\# rowData names(0): \#\# colnames(10): naive.1 rTreg.2 \... act_naive.9 act_rTreg.10 \#\# colData names(11): Sample_Name Sample_Well \... filenames \#\# predictedSex \#\# Annotation \#\# array: IlluminaHumanMethylation450k \#\# annotation: ilmn12.hg19 \#\# Preprocessing \#\# Method: Raw (no normalization or bg correction) \#\# minfi version: 1.20.2 \#\# Manifest version: 0.4.0

Once the data has been filtered and normalised, it is often useful to re-examine the MDS plots to see if the relationship between the samples has changed. It is apparent from the new MDS plots that much of the inter-individual variation has been removed as this is no longer the first principal component ( [Figure 6](#f6){ref-type="fig"}), likely due to the removal of the SNP-affected CpG probes. However, the samples do still cluster by individual in the second dimension ( [Figure 6](#f6){ref-type="fig"} and [Figure 7](#f7){ref-type="fig"}) and thus a factor for individual should still be included in the model.

par ( mfrow=c ( 1 , 2 )) plotMDS ( getM (mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Group)\], cex= 0.8 ) legend ( \"right\" , legend=levels ( factor (targets\$Sample_Group)), text.col= pal, cex= 0.65 , bg= \"white\" ) plotMDS ( getM (mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Source)\]) legend ( \"right\" , legend=levels ( factor (targets\$Sample_Source)), text.col= pal, cex= 0.7 , bg= \"white\" )

par ( mfrow=c ( 1 , 3 )) \# Examine higher dimensions to look at other sources of variation plotMDS ( getM (mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Source)\], dim=c ( 1 , 3 )) legend ( \"right\" , legend=levels ( factor (targets\$Sample_Source)), text.col= pal, cex= 0.7 , bg= \"white\" ) plotMDS ( getM (mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Source)\], dim=c ( 2 , 3 )) legend ( \"topright\" , legend=levels ( factor (targets\$Sample_Source)), text.col= pal, cex= 0.7 , bg= \"white\" ) plotMDS ( getM (mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= pal\[ factor (targets\$Sample_Source)\], dim=c ( 3 , 4 )) legend ( \"right\" , legend=levels ( factor (targets\$Sample_Source)), text.col= pal, cex= 0.7 , bg= \"white\" )

![Removing SNP-affected CpGs probes from the data changes the sample clustering in the MDS plots.](f1000research-5-12222-g0005){#f6}

![Examining the higher dimensions of the MDS plots shows that significant inter-individual variation still exists in the second and third principal components.](f1000research-5-12222-g0006){#f7}

The next step is to calculate M-values and beta values ( [Figure 8](#f8){ref-type="fig"}). As previously mentioned, M-values have nicer statistical properties and are thus better for use in statistical analysis of methylation data whilst beta values are easy to interpret and are thus better for displaying data. A detailed comparison of M-values and beta values was published by [@ref-10].

\# calculate M-values for statistical analysis mVals \<- getM (mSetSqFlt) head (mVals\[, 1 : 5 \])

\#\# naive.1 rTreg.2 act_naive.3 naive.4 act_naive.5 \#\# cg13869341 2.421276 2.515948 2.165745 2.286314 2.109441 \#\# cg24669183 2.169414 2.235964 2.280734 1.632309 2.184435 \#\# cg15560884 1.761176 1.577578 1.597503 1.777486 1.764999 \#\# cg01014490 -3.504268 -3.825119 -5.384735 -4.537864 -4.296526 \#\# cg17505339 3.082191 3.924931 4.163206 3.255373 3.654134 \#\# cg11954957 1.546401 1.912204 1.727910 2.441267 1.618331

bVals \<- getBeta (mSetSqFlt) head (bVals\[, 1 : 5 \])

\#\# naive.1 rTreg.2 act_naive.3 naive.4 act_naive.5 \#\# cg13869341 0.84267937 0.85118462 0.8177504 0.82987650 0.81186174 \#\# cg24669183 0.81812908 0.82489238 0.8293297 0.75610281 0.81967323 \#\# cg15560884 0.77219626 0.74903910 0.7516263 0.77417882 0.77266205 \#\# cg01014490 0.08098986 0.06590459 0.0233755 0.04127262 0.04842397 \#\# cg17505339 0.89439216 0.93822870 0.9471357 0.90520570 0.92641305 \#\# cg11954957 0.74495496 0.79008516 0.7681146 0.84450764 0.75431167

par ( mfrow=c ( 1 , 2 )) densityPlot (bVals, sampGroups= targets\$Sample_Group, main= \"Beta values\" , legend= FALSE , xlab= \"Beta values\" ) legend ( \"top\" , legend = levels ( factor (targets\$Sample_Group)), text.col=brewer.pal ( 8 , \"Dark2\" )) densityPlot (mVals, sampGroups= targets\$Sample_Group, main= \"M-values\" , legend= FALSE , xlab= \"M values\" ) legend ( \"topleft\" , legend = levels ( factor (targets\$Sample_Group)), text.col=brewer.pal ( 8 , \"Dark2\" ))

![The distributions of beta and M-values are quite different; beta values are constrained between 0 and 1 whilst M-values range between -Inf and Inf.](f1000research-5-12222-g0007){#f8}

Probe-wise differential methylation analysis
--------------------------------------------

The biological question of interest for this particular dataset is to discover differentially methylated probes between the different cell types. However, as was apparent in the MDS plots, there is another factor that we need to take into account when we perform the statistical analysis. In the `targets` file, there is a column called `Sample_Source`, which refers to the individuals that the samples were collected from. In this dataset, each of the individuals contributes more than one cell type. For example, individual M28 contributes `naive`, `rTreg` and `act_naive` samples. Hence, when we specify our design matrix, we need to include two factors: individual and cell type. This style of analysis is called a paired analysis; differences between cell types are calculated *within* each individual, and then these differences are averaged *across* individuals to determine whether there is an overall significant difference in the mean methylation level for each CpG site. The *limma* [User's Guide](https://bioconductor.org/packages/release/bioc/vignettes/limma/inst/doc/usersguide.pdf) extensively covers the different types of designs that are commonly used for microarray experiments and how to analyse them in R.

We are interested in pairwise comparisons between the four cell types, taking into account individual to individual variation. We perform this analysis on the matrix of M-values in *limma*, obtaining moderated t-statistics and associated p-values for each CpG site. A convenient way to set up the model when the user has many comparisons of interest that they would like to test is to use a contrasts matrix in conjunction with the design matrix. A contrasts matrix will take linear combinations of the columns of the design matrix corresponding to the comparisons of interest.

Since we are performing hundreds of thousands of hypothesis tests, we need to adjust the p-values for multiple testing. A common procedure for assessing how statistically significant a change in mean levels is between two groups when a very large number of tests is being performed is to assign a cut-off on the false discovery rate ( [@ref-3]), rather than on the unadjusted p-value. Typically 5% FDR is used, and this is interpreted as the researcher willing to accept that from the list of significant differentially methylated CpG sites, 5% will be false discoveries. If the p-values are not adjusted for multiple testing, the number of false discoveries will be unacceptably high. For this dataset, assuming a Type I error rate of 5%, we would expect to see 0.05\*439918=21996 statistical significant results for a given comparison, even if there were truly no differentially methylated CpG sites.

Based on a false discovery rate of 5%, there are 3021 significantly differentially methylated CpGs in the `naïve` vs `rTreg` comparison, while `rTreg` vs `act_rTreg` doesn't show any significant differential methylation.

\# this is the factor of interest cellType \<- factor (targets\$Sample_Group) \# this is the individual effect that we need to account for individual \<- factor (targets\$Sample_Source) \# use the above to create a design matrix design \<- model.matrix (\~ 0 +cellType+individual, data= targets) colnames (design) \<- c ( levels (cellType), levels (individual)\[- 1 \]) \# fit the linear model fit \<- lmFit (mVals, design) \# create a contrast matrix for specific comparisons contMatrix \<- makeContrasts (naive-rTreg, naive-act_naive, rTreg-act_rTreg, act_naive-act_rTreg, levels= design) contMatrix

\#\# Contrasts \#\# Levels naive - rTreg naive - act_naive rTreg - act_rTreg \#\# act_naive 0 -1 0 \#\# act_rTreg 0 0 -1 \#\# naive 1 1 0 \#\# rTreg -1 0 1 \#\# M29 0 0 0 \#\# M30 0 0 0 \#\# Contrasts \#\# Levels act_naive - act_rTreg \#\# act_naive 1 \#\# act_rTreg -1 \#\# naive 0 \#\# rTreg 0 \#\# M29 0 \#\# M30 0

\# fit the contrasts fit2 \<- contrasts.fit (fit, contMatrix) fit2 \<- eBayes (fit2) \# look at the numbers of DM CpGs at FDR \< 0.05 summary ( decideTests (fit2))

\#\# naive - rTreg naive - act_naive rTreg - act_rTreg act_naive - act_rTreg \#\# -1 1618 400 0 559 \#\# 0 436897 439291 439918 438440 \#\# 1 1403 227 0 919

We can extract the tables of differentially expressed CpGs for each comparison, ordered by B-statistic by default, using the `topTable` function in *limma*. The B-statistic is the log-odds of differential methylation, first published by Lonnstedt and Speed ( [@ref-22]). To order by p-value, the user can specify `sort.by="p"`; and in most cases, the ordering based on the p-value and ordering based on the B-statistic will be identical. The results of the analysis for the first comparison, `naive` vs. `rTreg`, can be saved as a `data.frame` by setting `coef=1`. The `coef` parameter explicitly refers to the column in the contrasts matrix which corresponds to the comparison of interest.

\# get the table of results for the first contrast (naive - rTreg) ann450kSub \<- ann450k\[ match ( rownames (mVals),ann450k\$Name), c ( 1 : 4 , 12 : 19 , 24 : ncol (ann450k))\] DMPs \<- topTable (fit2, num= Inf , coef= 1 , genelist= ann450kSub) head (DMPs)

\#\# chr pos strand Name Probe_rs Probe_maf CpG_rs \#\# cg07499259 chr1 12188502 + cg07499259 \<NA\> NA \<NA\> \#\# cg26992245 chr8 29848579 - cg26992245 \<NA\> NA \<NA\> \#\# cg09747445 chr15 70387268 - cg09747445 \<NA\> NA \<NA\> \#\# cg18808929 chr8 61825469 - cg18808929 \<NA\> NA \<NA\> \#\# cg25015733 chr2 99342986 - cg25015733 \<NA\> NA \<NA\> \#\# cg21179654 chr3 114057297 + cg21179654 \<NA\> NA \<NA\> \#\# CpG_maf SBE_rs SBE_maf Islands_Name \#\# cg07499259 NA \<NA\> NA \#\# cg26992245 NA \<NA\> NA \#\# cg09747445 NA \<NA\> NA chr15:70387929-70393206 \#\# cg18808929 NA \<NA\> NA chr8:61822358-61823028 \#\# cg25015733 NA \<NA\> NA chr2:99346882-99348177 \#\# cg21179654 NA \<NA\> NA \#\# Relation_to_Island \#\# cg07499259 OpenSea \#\# cg26992245 OpenSea \#\# cg09747445 N_Shore \#\# cg18808929 S_Shelf \#\# cg25015733 N_Shelf \#\# cg21179654 OpenSea \#\# UCSC_RefGene_Name \#\# cg07499259 TNFRSF8;TNFRSF8 \#\# cg26992245 \#\# cg09747445 TLE3;TLE3;TLE3 \#\# cg18808929 \#\# cg25015733 MGAT4A \#\# cg21179654 ZBTB20;ZBTB20;ZBTB20;ZBTB20;ZBTB20;ZBTB20;ZBTB20 \#\# \#\# \#\# UCSC_RefGene_Accession \#\# cg07499259 NM_152942;NM_001243 \#\# cg26992245 \#\# cg09747445 \#\# cg18808929 \#\# cg25015733 \#\# cg21179654 NM_001164343;NM_001164346;NM_001164345;NM_001164342; \#\# UCSC_RefGene_Group Phantom DMR Enhancer \#\# cg07499259 5\'UTR;Body \#\# cg26992245 TRUE \#\# cg09747445 Body;Body;Body \#\# cg18808929 TRUE \#\# cg25015733 5\'UTR \#\# cg21179654 3\'UTR;3\'UTR;3\'UTR;3\'UTR;3\'UTR;3\'UTR;3\'UTR \#\# HMM_Island Regulatory_Feature_Name \#\# cg07499259 1:12111023-12111225 \#\# cg26992245 \#\# cg09747445 \#\# cg18808929 \#\# cg25015733 \#\# cg21179654 3:114057192-114057775 \#\# Regulatory_Feature_Group DHS logFC AveExpr \#\# cg07499259 3.654104 2.46652171 \#\# cg26992245 4.450696 -0.09180715 \#\# cg09747445 -3.337299 -0.25201484 \#\# cg18808929 -2.990263 0.77522878 \#\# cg25015733 -3.054336 0.83280190 \#\# cg21179654 Unclassified_Cell_type_specific 2.859016 1.32460816 \#\# t P.Value adj.P.Val B \#\# cg07499259 18.73131 7.267204e-08 0.005067836 7.453206 \#\# cg26992245 18.32674 8.615461e-08 0.005067836 7.359096 \#\# cg09747445 -18.24438 8.923101e-08 0.005067836 7.339443 \#\# cg18808929 -17.90181 1.034217e-07 0.005067836 7.255825 \#\# cg25015733 -17.32615 1.333546e-07 0.005067836 7.108231 \#\# cg21179654 17.27804 1.362674e-07 0.005067836 7.095476

The resulting `data.frame` can easily be written to a CSV file, which can be opened in Excel.

write.table (DMPs, file= \"DMPs.csv\" , sep= \",\" , row.names= FALSE )

It is always useful to plot sample-wise methylation levels for the top differentially methylated CpG sites to quickly ensure the results make sense ( [Figure 9](#f9){ref-type="fig"}). If the plots do not look as expected, it is usually an indication of an error in the code, or in setting up the design matrix. It is easier to interpret methylation levels on the beta value scale, so although the analysis is performed on the M-value scale, we visualise data on the beta value scale. The `plotCpg` function in *minfi* is a convenient way to plot the sample-wise beta values stratified by the grouping variable.

\# plot the top 4 most significantly differentially methylated CpGs par ( mfrow=c ( 2 , 2 )) sapply ( rownames (DMPs)\[ 1 : 4 \], function(cpg){ plotCpg ( bVals, cpg= cpg, pheno= targets\$Sample_Group, ylab = \"Beta values\" ) })

\#\# \$cg07499259 \#\# NULL \#\# \#\# \$cg26992245 \#\# NULL \#\# \#\# \$cg09747445 \#\# NULL \#\# \#\# \$cg18808929 \#\# NULL

Differential methylation analysis of regions
--------------------------------------------

Although performing a *probe-wise* analysis is useful and informative, sometimes we are interested in knowing whether several proximal CpGs are concordantly differentially methylated, that is, we want to identify differentially methylated *regions*. There are several Bioconductor packages that have functions for identifying differentially methylated regions from 450k data. Some of the most popular are the `dmrFind` function in the [charm](http://www.bioconductor.org/packages/release/bioc/html/charm.html) package, which has been somewhat superseded for 450k arrays by the `bumphunter` function in [minfi](http://bioconductor.org/packages/release/bioc/html/minfi.html)( [@ref-1]; [@ref-19]), and, the recently published `dmrcate` in the [DMRcate](https://www.bioconductor.org/packages/release/bioc/html/DMRcate.html) package ( [@ref-27]). They are each based on different statistical methods. In our experience, the `bumphunter` and `dmrFind` functions can be somewhat slow to run unless you have the computer infrastructure to parallelise them, as they use permutations to assign significance. In this workflow, we will perform an analysis using the `dmrcate`. As it is based on *limma*, we can directly use the `design` and `contMatrix` we previously defined.

Firstly, our matrix of M-values is annotated with the relevant information about the probes such as their genomic position, gene annotation, etc. By default, this is done using the `ilmn12.hg19` annotation, but this can be substituted for any argument compatible with the interface provided by the *minfi* package. The *limma* pipeline is then used for differential methylation analysis to calculate moderated t-statistics.

![Plotting the top few differentially methylated CpGs is a good way to check whether the results make sense.](f1000research-5-12222-g0008){#f9}

myAnnotation \<- cpg.annotate ( object = mVals, datatype = \"array\" , what = \"M\" , analysis.type= \"differential\" , design = design, contrasts = TRUE , cont.matrix = contMatrix, coef = \"naive - rTreg\" , arraytype = \"450K\" )

\#\# Your contrast returned 3021 individually significant probes. \#\# We recommend the default setting of pcutoff in dmrcate().

str (myAnnotation)

\#\# List of 7 \#\# \$ ID :Factor w/ 439918 levels \"cg00000029\",\"cg00000108\",..: 232388 391918 260351 \... \#\# \$ stat : num \[1:439918\] 0.0489 -2.0773 0.7711 -0.0304 -0.764 \... \#\# \$ CHR : Factor w/ 24 levels \"chr1\",\"chr10\",..: 1 1 1 1 1 1 1 1 1 1 \... \#\# \$ pos : int \[1:439918\] 15865 534242 710097 714177 720865 758829 763119 779995 \... \#\# \$ betafc: num \[1:439918\] 0.00039 -0.04534 0.01594 0.00251 -0.00869 \... \#\# \$ indfdr: num \[1:439918\] 0.994 0.565 0.872 0.997 0.873 \... \#\# \$ is.sig: logi \[1:439918\] FALSE FALSE FALSE FALSE FALSE FALSE \... \#\# - attr(\*, \"row.names\")= int \[1:439918\] 1 2 3 4 5 6 7 8 9 10 \... \#\# - attr(\*, \"class\")= chr \"annot\"

Once we have the relevant statistics for the individual CpGs, we can then use the `dmrcate` function to combine them to identify differentially methylated regions. The main output table `DMRs$results` contains all of the regions found, along with their genomic annotations and p-values.

DMRs \<- dmrcate (myAnnotation, lambda= 1000 , C= 2 ) head (DMRs\$results)

\#\# coord no.cpgs minfdr Stouffer \#\# 452 chr17:57915665-57918682 12 4.957890e-91 6.639928e-10 \#\# 723 chr3:114012316-114012912 5 1.622885e-180 1.515378e-07 \#\# 464 chr17:74639731-74640078 6 9.516873e-90 1.527961e-07 \#\# 1053 chrX:49121205-49122718 6 6.753751e-84 2.936984e-07 \#\# 487 chr18:21452730-21453131 7 5.702319e-115 7.674943e-07 \#\# 186 chr10:135202522-135203200 6 1.465070e-65 7.918224e-07 \#\# maxbetafc meanbetafc \#\# 452 0.3982862 0.3131611 \#\# 723 0.5434277 0.4251622 \#\# 464 -0.2528645 -0.1951904 \#\# 1053 0.4529088 0.3006242 \#\# 487 -0.3867474 -0.2546089 \#\# 186 0.2803157 0.2293419

As for the probe-wise analysis, it is advisable to visualise the results to ensure that they make sense. The regions can easily be viewed using the `DMR.plot` function provided in the *DMRcate* package ( [Figure 10](#f10){ref-type="fig"}).

\# convert the regions to annotated genomic ranges data (dmrcatedata) results.ranges \<- extractRanges (DMRs, genome = \"hg19\" )

\# set up the grouping variables and colours groups \<- pal\[ 1 : length ( unique (targets\$Sample_Group))\] names (groups) \<- levels ( factor (targets\$Sample_Group)) cols \<- groups\[ as.character ( factor (targets\$Sample_Group))\] samps \<- 1 : nrow (targets)

\# draw the plot for the top DMR par ( mfrow=c ( 1 , 1 )) DMR.plot(ranges= results.ranges, dmr= 1 , CpGs= bVals, phen.col= cols, what = \"Beta\" , arraytype = \"450K\" , pch= 16 , toscale= TRUE , plotmedians= TRUE , genome= \"hg19\" , samps= samps)

![The DMRcate "DMR.plot" function allows you to quickly visualise DMRs in their genomic context.\
By default, the plot shows the location of the DMR in the genome, the position of any genes that are nearby, the base pair positions of the CpG probes, the methylation levels of the individual samples as a heatmap and the mean methylation levels for the various sample groups in the experiment. This plot shows the top ranked DMR identified by the DMRcate analysis.](f1000research-5-12222-g0009){#f10}

Customising visualisations of methylation data
----------------------------------------------

The *Gviz* package offers powerful functionality for plotting methylation data in its genomic context. The package [vignette](https://bioconductor.org/packages/release/bioc/vignettes/Gviz/inst/doc/Gviz.pdf) is very extensive and covers the various types of plots that can be produced using the *Gviz* framework. We will plot one of the differentially methylated regions from the *DMRcate* analysis to demonstrate the type of visualisations that can be created ( [Figure 11](#f11){ref-type="fig"}).

![The Gviz package provides extensive functionality for customising plots of genomic regions.\
This plot shows the top ranked DMR identified by the DMRcate analysis.](f1000research-5-12222-g0010){#f11}

We will first set up the genomic region we would like to plot by extracting the genomic coordinates of the top differentially methylated region.

\# indicate which genome is being used gen \<- \"hg19\" \# the index of the DMR that we will plot dmrIndex \<- 1 \# extract chromosome number and location from DMR results coords \<- strsplit2 (DMRs\$results\$coord\[dmrIndex\], \":\" ) chrom \<- coords\[ 1 \] start \<- as.numeric( strsplit2 (coords\[ 2 \], \"-\" )\[ 1 \]) end \<- as.numeric ( strsplit2 (coords\[ 2 \], \"-\" )\[ 2\]) \# add 25% extra space to plot minbase \<- start - ( 0.25 \*(end-start)) maxbase \<- end + ( 0.25 \*(end-start))

Next, we will add some genomic annotations of interest such as the locations of CpG islands and DNAseI hypersensitive sites; this can be any feature or genomic annotation of interest that you have data available for. The CpG islands data was generated using the method published by [@ref-41]; the DNaseI hypersensitive site data was obtained from the [UCSC Genome Browser](https://genome.ucsc.edu/cgi-bin/hgTables).

\# CpG islands islandHMM \<- read.csv ( paste (dataDirectory, \"model-based-cpg-islands-hg19-chr17.txt\" , sep= \"/\" ), sep= \"\\t\" , stringsAsFactors= FALSE , header= FALSE ) head (islandHMM)

\#\# V1 V2 V3 V4 V5 V6 V7 V8 \#\# 1 chr17_ctg5_hap1 8935 10075 1141 129 815 0.714 0.887 \#\# 2 chr17_ctg5_hap1 64252 64478 227 30 165 0.727 1.014 \#\# 3 chr17_ctg5_hap1 87730 89480 1751 135 1194 0.682 0.663 \#\# 4 chr17_ctg5_hap1 98265 98591 327 29 226 0.691 0.744 \#\# 5 chr17_ctg5_hap1 120763 125451 4689 359 3032 0.647 0.733 \#\# 6 chr17_ctg5_hap1 146257 146607 351 19 231 0.658 0.500

islandData \<- GRanges ( seqnames=Rle (islandHMM\[, 1 \]), ranges=IRanges ( start= islandHMM\[, 2 \], end= islandHMM\[, 3 \]), strand=Rle ( strand ( rep ( \"\*\" , nrow (islandHMM))))) islandData

\#\# GRanges object with 3456 ranges and 0 metadata columns: \#\# seqnames ranges strand \#\# \<Rle\> \<IRanges\> \<Rle\> \#\# \[1\] chr17_ctg5_hap1 \[ 8935, 10075\] \* \#\# \[2\] chr17_ctg5_hap1 \[ 64252, 64478\] \* \#\# \[3\] chr17_ctg5_hap1 \[ 87730, 89480\] \* \#\# \[4\] chr17_ctg5_hap1 \[ 98265, 98591\] \* \#\# \[5\] chr17_ctg5_hap1 \[120763, 125451\] \* \#\# \... \... \... \... \#\# \[3452\] chr17 \[81147380, 81147511\] \* \#\# \[3453\] chr17 \[81147844, 81148321\] \* \#\# \[3454\] chr17 \[81152612, 81153665\] \* \#\# \[3455\] chr17 \[81156194, 81156512\] \* \#\# \[3456\] chr17 \[81162945, 81165532\] \* \#\# \-\-\-\-\-\-- \#\# seqinfo: 5 sequence from an unspecified genome; no seqlengths

\# DNAseI hypersensitive sites dnase \<- read.csv ( paste (dataDirectory, \"wgEncodeRegDnaseClusteredV3chr17.bed\" , sep= \"/\" ), sep= \"\\t\" , stringsAsFactors= FALSE , header= FALSE ) head (dnase)

\#\# V1 V2 V3 V4 V5 V6 V7 \#\# 1 chr17 125 335 7 444 7 84,83,88,90,77,87,89, \#\# 2 chr17 685 835 1 150 1 80, \#\# 3 chr17 2440 2675 13 410 13 0,30,102,104,38,47,61,68,122,1,51,73,75, \#\# 4 chr17 3020 3170 1 247 1 120, \#\# 5 chr17 3740 3890 2 161 2 71,73, \#\# 6 chr17 5520 6110 4 241 5 17,19,25,16,16, \#\# V8 \#\# 1 328,208,444,218,109,171,191, \#\# 2 150, \#\# 3 204,410,301,206,46,48,84,164,85,12,98,215,146, \#\# 4 247, \#\# 5 108,161, \#\# 6 241,185,239,26,52, dnaseData \<- GRanges ( seqnames= dnase\[, 1 \], ranges=IRanges ( start= dnase\[, 2 \], end= dnase\[, 3 \]), strand=Rle ( rep ( \"\*\" , nrow (dnase))), data= dnase\[, 5\]) dnaseData \#\# GRanges object with 74282 ranges and 1 metadata column: \#\# seqnames ranges strand \| data \#\# \<Rle\> \<IRanges\> \<Rle\> \| \<integer\> \#\# \[1\] chr17 \[ 125, 335\] \* \| 444 \#\# \[2\] chr17 \[ 685, 835\] \* \| 150 \#\# \[3\] chr17 \[2440, 2675\] \* \| 410 \#\# \[4\] chr17 \[3020, 3170\] \* \| 247 \#\# \[5\] chr17 \[3740, 3890\] \* \| 161 \#\# \... \... \... \... . \... \#\# \[74278\] chr17 \[81153140, 81153350\] \* \| 574 \#\# \[74279\] chr17 \[81153580, 81153810\] \* \| 208 \#\# \[74280\] chr17 \[81185540, 81185750\] \* \| 326 \#\# \[74281\] chr17 \[81188880, 81189090\] \* \| 209 \#\# \[74282\] chr17 \[81194900, 81195115\] \* \| 185 \#\# \-\-\-\-\-\-- \#\# seqinfo: 1 sequence from an unspecified genome; no seqlengths

Now, set up the ideogram, genome and RefSeq tracks that will provide context for our methylation data.

iTrack \<- IdeogramTrack ( genome = gen, chromosome = chrom, name= \"\" ) gTrack \<- GenomeAxisTrack ( col= \"black\" , cex= 1 , name= \"\" , fontcolor= \"black\" ) rTrack \<- UcscTrack ( genome= gen, chromosome= chrom, track= \"refGene\" , from= minbase, to= maxbase, trackType= \"GeneRegionTrack\" , rstarts= \"exonStarts\" , rends= \"exonEnds\" , gene= \"name\" , symbol= \"name2\" , transcript= \"name\" , strand= \"strand\" , fill= \"darkblue\" , stacking= \"squish\" , name= \"RefSeq\" , showId= TRUE , geneSymbol= TRUE )

Ensure that the methylation data is ordered by chromosome and base position.

ann450kOrd \<- ann450kSub\[ order (ann450kSub\$chr,ann450kSub\$pos),\] head (ann450kOrd) \#\# DataFrame with 6 rows and 22 columns \#\# chr pos strand Name Probe_rs \#\# \<character\> \<integer\> \<character\> \<character\> \<character\> \#\# cg13869341 chr1 15865 + cg13869341 NA \#\# cg24669183 chr1 534242 - cg24669183 rs6680725 \#\# cg15560884 chr1 710097 + cg15560884 NA \#\# cg01014490 chr1 714177 - cg01014490 NA \#\# cg17505339 chr1 720865 - cg17505339 NA \#\# cg11954957 chr1 758829 + cg11954957 rs115498424 \#\# Probe_maf CpG_rs CpG_maf SBE_rs SBE_maf \#\# \<numeric\> \<character\> \<numeric\> \<character\> \<numeric\> \#\# cg13869341 NA NA NA NA NA \#\# cg24669183 0.108100 NA NA NA NA \#\# cg15560884 NA NA NA NA NA \#\# cg01014490 NA NA NA NA NA \#\# cg17505339 NA NA NA NA NA \#\# cg11954957 0.029514 NA NA NA NA \#\# Islands_Name Relation_to_Island UCSC_RefGene_Name \#\# \<character\> \<character\> \<character\> \#\# cg13869341 OpenSea WASH5P \#\# cg24669183 chr1:533219-534114 S_Shore \#\# cg15560884 chr1:713984-714547 N_Shelf \#\# cg01014490 chr1:713984-714547 Island \#\# cg17505339 OpenSea \#\# cg11954957 chr1:762416-763445 N_Shelf \#\# UCSC_RefGene_Accession UCSC_RefGene_Group Phantom \#\# \<character\> \<character\> \<character\> \#\# cg13869341 NR_024540 Body \#\# cg24669183 \#\# cg15560884 \#\# cg01014490 \#\# cg17505339 \#\# cg11954957 \#\# DMR Enhancer HMM_Island Regulatory_Feature_Name \#\# \<character\> \<character\> \<character\> \<character\> \#\# cg13869341 \#\# cg24669183 1:523025-524193 \#\# cg15560884 \#\# cg01014490 1:703784-704410 1:713802-715219 \#\# cg17505339 \#\# cg11954957 \#\# Regulatory_Feature_Group DHS \#\# \<character\> \<character\> \#\# cg13869341 \#\# cg24669183 \#\# cg15560884 \#\# cg01014490 Promoter_Associated \#\# cg17505339 \#\# cg11954957 bValsOrd \<- bVals\[ match (ann450kOrd\$Name, rownames (bVals)),\] head (bValsOrd) \#\# naive.1 rTreg.2 act_naive.3 naive.4 act_naive.5 \#\# cg13869341 0.84267937 0.85118462 0.8177504 0.82987650 0.81186174 \#\# cg24669183 0.81812908 0.82489238 0.8293297 0.75610281 0.81967323 \#\# cg15560884 0.77219626 0.74903910 0.7516263 0.77417882 0.77266205 \#\# cg01014490 0.08098986 0.06590459 0.0233755 0.04127262 0.04842397 \#\# cg17505339 0.89439216 0.93822870 0.9471357 0.90520570 0.92641305 \#\# cg11954957 0.74495496 0.79008516 0.7681146 0.84450764 0.75431167 \#\# act_rTreg.6 naive.7 rTreg.8 act_naive.9 act_rTreg.10 \#\# cg13869341 0.8090798 0.8891851 0.88537940 0.90916748 0.88334231 \#\# cg24669183 0.8187838 0.7903763 0.85304116 0.80930568 0.80979554 \#\# cg15560884 0.7721528 0.7658623 0.75909061 0.78099397 0.78569274 \#\# cg01014490 0.0644404 0.0245281 0.02832358 0.07740468 0.04640659 \#\# cg17505339 0.9286016 0.8889361 0.87205348 0.90099782 0.93508348 \#\# cg11954957 0.8116911 0.7832207 0.84929777 0.84719430 0.83350220

Create the data tracks using the appropriate track type for each data type.

\# create genomic ranges object from methylation data cpgData \<- GRanges ( seqnames=Rle (ann450kOrd\$chr), ranges=IRanges ( start= ann450kOrd\$pos, end= ann450kOrd\$pos), strand=Rle ( rep ( \"\*\" , nrow (ann450kOrd))), betas= bValsOrd) \# extract data on CpGs in DMR cpgData \<- subsetByOverlaps (cpgData, results.ranges\[dmrIndex\]) \# methylation data track methTrack \<- DataTrack ( range= cpgData, groups= targets\$Sample_Group, genome = gen, chromosome= chrom, ylim=c (- 0.05 , 1.05 ), col= pal, type=c ( \"a\" , \"p\" ), name= \"DNA Meth.\\n(beta value)\" , background.panel= \"white\" , legend= TRUE , cex.title= 0.8 , cex.axis= 0.8 , cex.legend= 0.8 ) \# CpG island track islandTrack \<- AnnotationTrack ( range= islandData, genome= gen, name= \"CpG Is.\" , chromosome= chrom, fill= \"darkgreen\" ) \# DNaseI hypersensitive site data track dnaseTrack \<- DataTrack ( range= dnaseData, genome= gen, name= \"DNAseI\" , type= \"gradient\" , chromosome= chrom) \# DMR position data track dmrTrack \<- AnnotationTrack ( start= start, end= end, genome= gen, name= \"DMR\" , chromosome= chrom, fill= \"darkred\" )

Set up the track list and indicate the relative sizes of the different tracks. Finally, draw the plot using the `plotTracks` function ( [Figure 11](#f11){ref-type="fig"}).

tracks \<- list (iTrack, gTrack, methTrack, dmrTrack, islandTrack, dnaseTrack, rTrack) sizes \<- c ( 2 , 2 , 5 , 2 , 2 , 2 , 3 ) \# set up the relative sizes of the tracks plotTracks (tracks, from= minbase, to= maxbase, showTitle= TRUE , add53= TRUE , add35= TRUE , grid= TRUE , lty.grid= 3 , sizes= sizes, length (tracks))

Additional analyses
===================

Gene ontology testing
---------------------

Once you have performed a differential methylation analysis, there may be a very long list of significant CpG sites to interpret. One question a researcher may have is, "which gene pathways are over-represented for differentially methylated CpGs?" In some cases it is relatively straightforward to link the top differentially methylated CpGs to genes that make biological sense in terms of the cell types or samples being studied, but there may be many thousands of CpGs significantly differentially methylated. In order to gain an understanding of the biological processes that the differentially methylated CpGs may be involved in, we can perform gene ontology or KEGG pathway analysis using the `gometh` function in the *missMethyl* package ( [@ref-28]).

Let us consider the first comparison, naive vs rTreg, with the results of the analysis in the `DMPs` table. The `gometh` function takes as input a character vector of the names (e.g. cg20832020) of the significant CpG sites, and optionally, a character vector of all CpGs tested. This is recommended particularly if extensive filtering of the CpGs has been performed prior to analysis. For gene ontology testing (default), the user can specify `collection="GO”`. For testing KEGG pathways, specify `collection="KEGG”`. In the `DMPs` table, the `Name` column corresponds to the CpG name. We will select all CpG sites that have adjusted p-value of less than 0.05.

\# Get the significant CpG sites at less than 5% FDR sigCpGs \<- DMPs\$Name\[DMPs\$adj.P.Val\< 0.05 \] \# First 10 significant CpGs sigCpGs\[ 1 : 10 \] \#\# \[1\] \"cg07499259\" \"cg26992245\" \"cg09747445\" \"cg18808929\" \"cg25015733\" \#\# \[6\] \"cg21179654\" \"cg26280976\" \"cg16943019\" \"cg10898310\" \"cg25130381\" \# Total number of significant CpGs at 5% FDR length (sigCpGs) \#\# \[1\] 3021 \# Get all the CpG sites used in the analysis to form the background all \<- DMPs\$Name \# Total number of CpG sites tested length (all) \#\# \[1\] 439918

The `gometh` function takes into account the varying numbers of CpGs associated with each gene on the Illumina methylation arrays. For the 450k array, the numbers of CpGs mapping to genes can vary from as few as 1 to as many as 1200. The genes that have more CpGs associated with them will have a higher probability of being identified as differentially methylated compared to genes with fewer CpGs. We can look at this bias in the data by specifying `plot=TRUE` in the call to `gometh` ( [Figure 12](#f12){ref-type="fig"}).

![Bias resulting from different numbers of CpG probes in different genes.](f1000research-5-12222-g0011){#f12}

par ( mfrow=c ( 1 , 1 )) gst \<- gometh ( sig.cpg= sigCpGs, all.cpg= all, plot.bias= TRUE ) \#\# Warning in alias2SymbolTable(flat\$symbol): Multiple symbols ignored for one \#\# or more aliases

The `gst` object is a `data.frame` with each row corresponding to the GO category being tested. Note that the warning regarding multiple symbols will always be displayed as there are genes that have more than one alias, however it is not a cause for concern.

The top 20 gene ontology categories can be displayed using the `topGO` function. For KEGG pathway analysis, the `topKEGG` function can be called to display the top 20 enriched pathways.

\# Top 10 GO categories topGO (gst, number= 10 ) \#\# Term Ont N DE \#\# GO:0002376 immune system process BP 2240 340 \#\# GO:0006955 immune response BP 1409 212 \#\# GO:0001775 cell activation BP 837 158 \#\# GO:0007159 leukocyte cell-cell adhesion BP 455 103 \#\# GO:0046649 lymphocyte activation BP 574 119 \#\# GO:0002682 regulation of immune system process BP 1225 195 \#\# GO:0045321 leukocyte activation BP 676 130 \#\# GO:0070486 leukocyte aggregation BP 423 96 \#\# GO:0042110 T cell activation BP 415 94 \#\# GO:0070489 T cell aggregation BP 415 94 \#\# P.DE \#\# GO:0002376 0.000000000000000000000000000003229702 \#\# GO:0006955 0.000000000000000000000422272703517178 \#\# GO:0001775 0.000000000000000000010295538258512461 \#\# GO:0007159 0.000000000000000000090040070213398411 \#\# GO:0046649 0.000000000000000000250620553154991038 \#\# GO:0002682 0.000000000000000000263741544330346864 \#\# GO:0045321 0.000000000000000001995676602987099282 \#\# GO:0070486 0.000000000000000002407114373683902864 \#\# GO:0042110 0.000000000000000004264084670812330066 \#\# GO:0070489 0.000000000000000004264084670812330066 \#\# FDR \#\# GO:0002376 0.00000000000000000000000006820484 \#\# GO:0006955 0.00000000000000000445877747643788 \#\# GO:0001775 0.00000000000000007247372564775539 \#\# GO:0007159 0.00000000000000047536655069163696 \#\# GO:0046649 0.00000000000000092828232219471078 \#\# GO:0002682 0.00000000000000092828232219471078 \#\# GO:0045321 0.00000000000000602067121455450880 \#\# GO:0070486 0.00000000000000635418016793208260 \#\# GO:0042110 0.00000000000000900489400782147891 \#\# GO:0070489 0.00000000000000900489400782147891

From the output we can see many of the top GO categories correspond to immune system and T cell processes, which is unsurprising as the cell types being studied form part of the immune system. Typically, we consider GO categories that have associated false discovery rates of less than 5% to be statistically significant. If there aren't any categories that achieve this significance it may be useful to scan the top 5 or 10 highly ranked GO categories to gain some insight into the biological system.

The `gometh` function only tests GO and KEGG pathways. For a more generalised version of gene set testing for methylation data where the user can specify the gene set to be tested, the `gsameth` function can be used. To display the top 20 pathways, `topGSA` can be called. `gsameth` accepts a single gene set, or a list of gene sets. The gene identifiers in the gene set must be Entrez Gene IDs. To demonstrate `gsameth`, we are using the curated genesets (C2) from the Broad Institute Molecular signatures [database](http://software.broadinstitute.org/gsea/msigdb). These can be downloaded as an `RData` object from the WEHI Bioinformatics [website](http://bioinf.wehi.edu.au/software/MSigDB/).

\# load Broad human curated (C2) gene sets load ( paste (dataDirectory, \"human_c2_v5.rdata\" , sep= \"/\" )) \# perform the gene set test(s) gsa \<- gsameth ( sig.cpg= sigCpGs, all.cpg= all, collection= Hs.c2)

\#\# Warning in alias2SymbolTable(flat\$symbol): Multiple symbols ignored for one \#\# or more aliases

\# top 10 gene sets topGSA (gsa, number= 10 )

\#\# N DE P.DE \#\# REACTOME_IMMUNE_SYSTEM 933 127 0.000000000000000000000000 \#\# DACOSTA_UV_RESPONSE_VIA_ERCC3_DN 855 147 0.000000000000000000000000 \#\# ZHENG_BOUND_BY_FOXP3 491 138 0.000000000000000000000000 \#\# MARSON_BOUND_BY_FOXP3_UNSTIMULATED 1229 169 0.000000000000000000000000 \#\# CHEN_METABOLIC_SYNDROM_NETWORK 1210 162 0.000000000000000000000000 \#\# MARTENS_BOUND_BY_PML_RARA_FUSION 456 105 0.000000000000000000000000 \#\# PILON_KLF1_TARGETS_DN 1972 262 0.000000000000000000000000 \#\# JAATINEN_HEMATOPOIETIC_STEM_CELL_DN 226 59 0.000000000000000004151028 \#\# SMID_BREAST_CANCER_NORMAL_LIKE_UP 476 92 0.000000000000002674784772 \#\# LEE_EARLY_T\_LYMPHOCYTE_DN 57 25 0.000000000000825660086765 \#\# FDR \#\# REACTOME_IMMUNE_SYSTEM 0.000000000000000000000 \#\# DACOSTA_UV_RESPONSE_VIA_ERCC3_DN 0.000000000000000000000 \#\# ZHENG_BOUND_BY_FOXP3 0.000000000000000000000 \#\# MARSON_BOUND_BY_FOXP3_UNSTIMULATED 0.000000000000000000000 \#\# CHEN_METABOLIC_SYNDROM_NETWORK 0.000000000000000000000 \#\# MARTENS_BOUND_BY_PML_RARA_FUSION 0.000000000000000000000 \#\# PILON_KLF1_TARGETS_DN 0.000000000000000000000 \#\# JAATINEN_HEMATOPOIETIC_STEM_CELL_DN 0.000000000000002451701 \#\# SMID_BREAST_CANCER_NORMAL_LIKE_UP 0.000000000001404262005 \#\# LEE_EARLY_T\_LYMPHOCYTE_DN 0.000000000390124390997

While gene set testing is useful for providing some biological insight in terms of what pathways might be affected by abberant methylation, care should be taken not to over-interpret the results. Gene set testing should be used for the purpose of providing some biological insight that ideally would be tested and validated in further laboratory experiments. It is important to keep in mind that we are not observing gene level activity such as in RNA-Seq experiments, and that we have had to take an extra step to associate CpGs with genes.

Differential variability {#DV}
------------------------

Rather than testing for differences in mean methylation, we may be interested in testing for differences between group variances. For example, it has been hypothesised that highly variable CpGs in cancer may contribute to tumour heterogeneity ( [@ref-13]). Hence we may be interested in CpG sites that are consistently methylated in one group, but variably methylated in another group.

Sample size is an important consideration when testing for differentially variable CpG sites. In order to get an accurate estimate of the group variances, larger sample sizes are required than for estimating group means. A good rule of thumb is to have at least ten samples in each group ( [@ref-29]). To demonstrate testing for differentially variable CpG sites, we will use a publicly available dataset on ageing GSE30870, where whole blood samples were collected from 18 centenarians and 18 newborns and profiled for methylation on the 450k array ( [@ref-14]). The data ( `age.rgSet`) and sample information ( `age.targets`) have been included as an R data object in the data archive you previously downloaded from [figshare](https://figshare.com/articles/methylAnalysisDataV3_tar_gz/4800970). We can load the data using the `load` command, after which it needs to be normalised and filtered as previously described.

\# load data load ( paste (dataDirectory, \"ageData.RData\" , sep= \"/\" )) \# calculate detection p-values age.detP \<- detectionP (age.rgSet) \# pre-process the data after excluding poor quality samples age.mSetSq \<- preprocessQuantile (age.rgSet)

\#\# \[preprocessQuantile\] Mapping to genome.

\#\# \[preprocessQuantile\] Fixing outliers.

\#\# \[preprocessQuantile\] Quantile normalizing.

\# add sex information to targets information age.targets\$Sex \<- getSex (age.mSetSq)\$predictedSex \# ensure probes are in the same order in the mSetSq and detP objects age.detP \<- age.detP\[ match ( featureNames (age.mSetSq), rownames (age.detP)),\] \# remove poor quality probes keep \<- rowSums (age.detP \< 0.01 ) == ncol (age.detP) age.mSetSqFlt \<- age.mSetSq\[keep,\] \# remove probes with SNPs at CpG or single base extension (SBE) site age.mSetSqFlt \<- dropLociWithSnps (age.mSetSqFlt, snps = c ( \"CpG\" , \"SBE\" )) \# remove cross-reactive probes keep \<- !( featureNames (age.mSetSqFlt) %in% xReactiveProbes\$TargetID) age.mSetSqFlt \<- age.mSetSqFlt\[keep,\]

As this dataset contains samples from both males and females, we can use it to demonstrate the effect of removing sex chromosome probes on the data. The MDS plots below show the relationship between the samples in the ageing dataset before and after sex chromosome probe removal ( [Figure 13](#f13){ref-type="fig"}). It is apparent that before the removal of sex chromosome probes, the sample cluster based on sex in the second principal component. When the sex chromosome probes are removed, age is the largest source of variation present and the male and female samples no longer form separate clusters.

\# tag sex chromosome probes for removal keep \<- !( featureNames (age.mSetSqFlt) %in% ann450k\$Name\[ann450k\$chr %in% c ( \"chrX\" , \"chrY\" )\]) age.pal \<- brewer.pal ( 8 , \"Set1\" ) par ( mfrow=c ( 1 , 2 )) plotMDS ( getM (age.mSetSqFlt), top= 1000 , gene.selection= \"common\" , col= age.pal\[ factor (age.targets\$Sample_Group)\], labels= age.targets\$Sex, main= \"With Sex CHR Probes\" ) legend ( \"topleft\" , legend=levels ( factor (age.targets\$Sample_Group)), text.col= age.pal) plotMDS ( getM (age.mSetSqFlt\[keep,\]), top= 1000 , gene.selection= \"common\" , col= age.pal\[ factor (age.targets\$Sample_Group)\], labels= age.targets\$Sex, main= \"Without Sex CHR Probes\" ) legend ( \"top\" , legend=levels ( factor (age.targets\$Sample_Group)), text.col= age.pal)

\# remove sex chromosome probes from data age.mSetSqFlt \<- age.mSetSqFlt\[keep,\]

![When samples from both males and females are included in a study, sex is usually the largest source of variation in methylation data.](f1000research-5-12222-g0012){#f13}

We can test for differentially variable CpGs using the `varFit` function in the *missMethyl* package. The syntax for specifying which groups we are interested in testing is slightly different to the standard way a model is specified in `limma`, particularly for designs where an intercept is fitted (see *missMethyl* [vignette](https://www.bioconductor.org/packages/release/bioc/vignettes/missMethyl/inst/doc/missMethyl.pdf) for further details). For the ageing data, the design matrix includes an intercept term, and a term for age. The `coef` argument in the `varFit` function indicates which columns of the design matrix correspond to the intercept and grouping factor. Thus, for the ageing dataset we set `coef=c(1,2)`. Note that design matrices without intercept terms are permitted, with specific contrasts tested using the `contrasts.varFit` function.

\# get M-values for analysis age.mVals \<- getM (age.mSetSqFlt) design \<- model.matrix (\~ factor (age.targets\$Sample_Group)) \# Fit the model for differential variability \# specifying the intercept and age as the grouping factor fitvar \<- varFit (age.mVals, design = design, coef = c ( 1 , 2 )) \# Summary of differential variability summary ( decideTests (fitvar))

\#\# (Intercept) factor(age.targets\$Sample_Group)OLD \#\# -1 0 1325 \#\# 0 11441 393451 \#\# 1 417787 34452

topDV \<- topVar (fitvar, coef= 2 ) \# Top 10 differentially variable CpGs between old vs. newborns topDV

\#\# SampleVar LogVarRatio DiffLevene t P.Value \#\# cg19078576 1.1128910 3.746586 0.8539180 7.006476 0.0000000006234780 \#\# cg11661000 0.5926226 3.881306 0.8413614 6.945711 0.0000000008176807 \#\# cg07065220 1.0111380 4.181802 0.9204407 6.840327 0.0000000013069867 \#\# cg05995465 1.4478673 -5.524284 -1.3035981 -6.708321 0.0000000023462074 \#\# cg18091046 1.1121511 3.564282 1.0983340 6.679920 0.0000000026599570 \#\# cg05491001 0.9276904 3.869760 0.7118591 6.675892 0.0000000027077013 \#\# cg05542681 1.0287320 3.783637 0.9352814 6.635588 0.0000000032347355 \#\# cg02726803 0.3175570 4.063650 0.6418968 6.607508 0.0000000036608219 \#\# cg08362283 1.0028907 4.783899 0.6970960 6.564472 0.0000000044240941 \#\# cg18160402 0.5624192 3.716228 0.5907985 6.520508 0.0000000053665347 \#\# Adj.P.Value \#\# cg19078576 0.0001754857 \#\# cg11661000 0.0001754857 \#\# cg07065220 0.0001869984 \#\# cg05995465 0.0001937035 \#\# cg18091046 0.0001937035 \#\# cg05491001 0.0001937035 \#\# cg05542681 0.0001964159 \#\# cg02726803 0.0001964159 \#\# cg08362283 0.0002109939 \#\# cg18160402 0.0002303467

Similarly to the differential methylation analysis, is it useful to plot sample-wise beta values for the differentially variable CpGs to ensure the significant results are not driven by artifacts or outliers ( [Figure 14](#f14){ref-type="fig"}).

![As for DMPs, it is useful to plot the top few differentially variable CpGs to check that the results make sense.](f1000research-5-12222-g0013){#f14}

\# get beta values for ageing data age.bVals \<- getBeta (age.mSetSqFlt)

par ( mfrow=c ( 2, 2 )) sapply ( rownames (topDV)\[ 1: 4 \], function(cpg){ plotCpg (age.bVals, cpg= cpg, pheno= age.targets\$Sample_Group, ylab = \"Beta values\" ) })

An example of testing for differential variability when the design matrix does not have an intercept term is detailed in the *missMethyl* [vignette](https://www.bioconductor.org/packages/release/bioc/vignettes/missMethyl/inst/doc/missMethyl.pdf/).

Cell type composition
---------------------

As methylation is cell type specific and methylation arrays provide CpG methylation values for a population of cells, biological findings from samples that are comprised of a mixture of cell types, such as blood, can be confounded with cell type composition ( [@ref-18]). The *minfi* function `estimateCellCounts` facilitates the estimation of the level of confounding between phenotype and cell type composition in a set of samples. The function uses a modified version of the method published by [@ref-16] and the package `FlowSorted.Blood.450k`, which contains 450k methylation data from sorted blood cells, to estimate the cell type composition of blood samples.

\# load sorted blood cell data package library (FlowSorted.Blood.450k) \# ensure that the \"Slide\" column of the rgSet pheno data is numeric \# to avoid \"estimateCellCounts\" error pData (age.rgSet)\$Slide \<- as.numeric ( pData (age.rgSet)\$Slide) \# estimate cell counts cellCounts \<- estimateCellCounts (age.rgSet)

*\#\# \[estimateCellCounts\] Combining user data with reference (flow sorted) data.* \#\# \[estimateCellCounts\] Processing user and reference data together. \#\# \[preprocessQuantile\] Mapping to genome. \#\# \[preprocessQuantile\] Fixing outliers. \#\# \[preprocessQuantile\] Quantile normalizing. \#\# \[estimateCellCounts\] Picking probes for composition estimation. \#\# \[estimateCellCounts\] Estimating composition.

\# plot cell type proportions by age par ( mfrow=c ( 1 , 1 )) a = cellCounts\[age.targets\$Sample_Group == \"NewBorns\" ,\] b = cellCounts\[age.targets\$Sample_Group == \"OLD\" ,\] boxplot (a, at= 0 : 5 \* 3 + 1 , xlim=c ( 0 , 18 ), ylim=range (a, b), xaxt= \"n\" , col= age.pal\[ 1 \], main= \"\" , ylab= \"Cell type proportion\" ) boxplot ( b , at= 0 : 5 \* 3 + 2 , xaxt= \"n\" , add= TRUE , col= age.pal \[ 2 \]) axis ( 1 , at= 0 : 5 \* 3 + 1.5 , labels=colnames (a), tick= TRUE ) legend ( \"topleft\" , legend=c ( \"NewBorns\" , \"OLD\" ), fill= age.pal)

As reported by [@ref-18], the preceding plot demonstrates that differences in blood cell type proportions are strongly confounded with age in this dataset ( [Figure 15](#f15){ref-type="fig"}). Performing cell composition estimation can alert you to potential issues with confounding when analysing a mixed cell type dataset. Based on the results, some type of adjustment for cell type composition may be considered, although a naive cell type adjustment is not recommended. [@ref-18] outline several strategies for dealing with cell type composition issues.

![If samples come from a population of mixed cells e.g. blood, it is advisable to check for potential confounding between differences in cell type proportions and the factor of interest.](f1000research-5-12222-g0014){#f15}

Discussion
==========

Here we present a commonly used workflow for methylation array analysis based on a series of Bio-conductor packages. While we have not included all the possible functions or analysis options that are available for detecting differential methylation, we have demonstrated a common and well used workflow that we regularly use in our own analysis. Specifically, we have not demonstrated more complex types of analyses such as removing unwanted variation in a differential methylation study ( [@ref-21]; [@ref-23]; [@ref-37]), block finding ( [@ref-1]; [@ref-13]) or A/B compartment prediction ( [@ref-11]). Our differential methylation workflow presented here demonstrates how to read in data, perform quality control and filtering, normalisation and differential methylation testing. In addition we demonstrate analysis for differential variability, gene set testing and estimating cell type composition. One important aspect of exploring results of an analysis is visualisation and we also provide an example of generating region-level views of the data.

Software versions
=================

The R markdown file and/or R script for this version workflow can be downloaded from: <https://github.com/Oshlack/MethylationAnalysisWorkflow/tree/version3/scripts>. A *live* version of this workflow that is regularly built using updated Bioconductor packages can be accessed on the Bioconductor website: <https://www.bioconductor.org/help/workflows/methylationArrayAnalysis/>. The version of the workflow presented here uses the following packages available from Bioconductor (release 3.4):

sessionInfo () \#\# R version 3.3.1 (2016-06-21) \#\# Platform: x86_64-pc-linux-gnu (64-bit) \#\# Running under: CentOS release 6.7 (Final) \#\# \#\# locale: \#\# \[1\] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C \#\# \[3\] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8 \#\# \[5\] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8 \#\# \[7\] LC_PAPER=en_US.UTF-8 LC_NAME=C \#\# \[9\] LC_ADDRESS=C LC_TELEPHONE=C \#\# \[11\] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C \#\# \#\# attached base packages: \#\# \[1\] splines grid stats4 parallel stats graphics grDevices \#\# \[8\] utils datasets methods base \#\# \#\# other attached packages: \#\# \[1\] stringr_1.2.0 \#\# \[2\] DMRcate_1.10.8 \#\# \[3\] DMRcatedata_1.10.1 \#\# \[4\] DSS_2.14.0 \#\# \[5\] bsseq_1.10.0 \#\# \[6\] Gviz_1.18.2 \#\# \[7\] minfiData_0.20.0 \#\# \[8\] matrixStats_0.51.0 \#\# \[9\] missMethyl_1.8.0 \#\# \[10\] RColorBrewer_1.1-2 \#\# \[11\] IlluminaHumanMethylation450kmanifest_0.4.0 \#\# \[12\] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.0 \#\# \[13\] minfi_1.20.2 \#\# \[14\] bumphunter_1.14.0 \#\# \[15\] locfit_1.5-9.1 \#\# \[16\] iterators_1.0.8 \#\# \[17\] foreach_1.4.3 \#\# \[18\] Biostrings_2.42.1 \#\# \[19\] XVector_0.14.1 \#\# \[20\] SummarizedExperiment_1.4.0 \#\# \[21\] GenomicRanges_1.26.4 \#\# \[22\] GenomeInfoDb_1.10.3 \#\# \[23\] IRanges_2.8.2 \#\# \[24\] S4Vectors_0.12.2 \#\# \[25\] Biobase_2.34.0 \#\# \[26\] BiocGenerics_0.20.0 \#\# \[27\] limma_3.30.13 \#\# \#\# loaded via a namespace (and not attached): \#\# \[1\] colorspace_1.3-2 \#\# \[2\] siggenes_1.48.0 \#\# \[3\] mclust_5.2.3 \#\# \[4\] rprojroot_1.2 \#\# \[5\] biovizBase_1.22.0 \#\# \[6\] htmlTable_1.9 \#\# \[7\] base64enc_0.1-3 \#\# \[8\] dichromat_2.0-0 \#\# \[9\] base64_2.0 \#\# \[10\] interactiveDisplayBase_1.12.0 \#\# \[11\] AnnotationDbi_1.36.2 \#\# \[12\] IlluminaHumanMethylationEPICanno.ilm10b2.hg19_0.6.0 \#\# \[13\] codetools_0.2-15 \#\# \[14\] R.methodsS3_1.7.1 \#\# \[15\] methylumi_2.20.0 \#\# \[16\] knitr_1.15.1 \#\# \[17\] Formula_1.2-1 \#\# \[18\] Rsamtools_1.26.1 \#\# \[19\] annotate_1.52.1 \#\# \[20\] cluster_2.0.5 \#\# \[21\] GO.db_3.4.0 \#\# \[22\] R.oo_1.21.0 \#\# \[23\] shiny_1.0.0 \#\# \[24\] httr_1.2.1 \#\# \[25\] backports_1.0.5 \#\# \[26\] assertthat_0.1 \#\# \[27\] Matrix_1.2-8 \#\# \[28\] lazyeval_0.2.0 \#\# \[29\] acepack_1.4.1 \#\# \[30\] htmltools_0.3.5 \#\# \[31\] tools_3.3.1 \#\# \[32\] gtable_0.2.0 \#\# \[33\] doRNG_1.6 \#\# \[34\] Rcpp_0.12.9 \#\# \[35\] multtest_2.30.0 \#\# \[36\] preprocessCore_1.36.0 \#\# \[37\] nlme_3.1-131 \#\# \[38\] rtracklayer_1.34.2 \#\# \[39\] mime_0.5 \#\# \[40\] ensembldb_1.6.2 \#\# \[41\] rngtools_1.2.4 \#\# \[42\] gtools_3.5.0 \#\# \[43\] statmod_1.4.29 \#\# \[44\] XML_3.98-1.5 \#\# \[45\] beanplot_1.2 \#\# \[46\] org.Hs.eg.db_3.4.0 \#\# \[47\] AnnotationHub_2.6.5 \#\# \[48\] zlibbioc_1.20.0 \#\# \[49\] MASS_7.3-45 \#\# \[50\] scales_0.4.1 \#\# \[51\] BSgenome_1.42.0 \#\# \[52\] VariantAnnotation_1.20.3 \#\# \[53\] BiocInstaller_1.24.0 \#\# \[54\] GEOquery_2.40.0 \#\# \[55\] yaml_2.1.14 \#\# \[56\] memoise_1.0.0 \#\# \[57\] gridExtra_2.2.1 \#\# \[58\] ggplot2_2.2.1 \#\# \[59\] pkgmaker_0.22 \#\# \[60\] biomaRt_2.30.0 \#\# \[61\] rpart_4.1-10 \#\# \[62\] reshape_0.8.6 \#\# \[63\] latticeExtra_0.6-28 \#\# \[64\] stringi_1.1.2 \#\# \[65\] RSQLite_1.1-2 \#\# \[66\] highr_0.6 \#\# \[67\] genefilter_1.56.0 \#\# \[68\] permute_0.9-4 \#\# \[69\] checkmate_1.8.2 \#\# \[70\] GenomicFeatures_1.26.3 \#\# \[71\] BiocParallel_1.8.1 \#\# \[72\] bitops_1.0-6 \#\# \[73\] nor1mix_1.2-2 \#\# \[74\] evaluate_0.10 \#\# \[75\] lattice_0.20-34 \#\# \[76\] ruv_0.9.6 \#\# \[77\] GenomicAlignments_1.10.1 \#\# \[78\] htmlwidgets_0.8 \#\# \[79\] plyr_1.8.4 \#\# \[80\] magrittr_1.5 \#\# \[81\] R6_2.2.0 \#\# \[82\] Hmisc_4.0-2 \#\# \[83\] DBI_0.6 \#\# \[84\] foreign_0.8-67 \#\# \[85\] survival_2.40-1 \#\# \[86\] RCurl_1.95-4.8 \#\# \[87\] nnet_7.3-12 \#\# \[88\] tibble_1.2 \#\# \[89\] rmarkdown_1.3 \#\# \[90\] data.table_1.10.4 \#\# \[91\] digest_0.6.12 \#\# \[92\] xtable_1.8-2 \#\# \[93\] httpuv_1.3.3 \#\# \[94\] illuminaio_0.16.0 \#\# \[95\] R.utils_2.5.0 \#\# \[96\] openssl_0.9.6 \#\# \[97\] munsell_0.4.3 \#\# \[98\] registry_0.3 \#\# \[99\] BiasedUrn_1.07 \#\# \[100\] quadprog_1.5-5
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I am happy with the amendments made, and approve of the publication.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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Thank you for making the data easily available and re-running the workflow with the latest release version of Bioconductor, Jovanna. My minor comments on the initial submission have also been addressed to my satisfaction. Therefore, I happily approve the revised manuscript. I believe it will be a helpful resource to the Bioconductor community and those wishing to learn best practises for analysing DNA methylation array data.

Minor comments I have on the revised manuscript: I got slightly different numbers and output when running the workflow (see below). I believe this is due to a bug being fixed in in v1.18.4 (see <https://github.com/Bioconductor-mirror/minfi/commit/c16b28e2f4c7127696cbea807f668d0a10c54b37>); I tested using minfi v1.18.6. These differences were first observable when running This affects all subsequent output such as which probes are identified as DMPs. Unfortunately, such changes in output are par for the course in bioinformatics software. These differences are outside the author\'s control, and I do not believe these affect the quality and usefulness of the workflow. I\'m not sure anything can be done except to point out that such differences may exist due to different software versions. \> head(mVals\[,1:5\])                      

                       naive.1     rTreg.2  act_naive.3    naive.4  act_naive.5

cg13869341  2.205808  2.205808    2.167697  2.173122    2.106660

cg24669183  2.169414  2.235964    2.280734  1.632309    2.184435

cg15560884  1.761176  1.577578    1.597503  1.777486    1.764999

cg01014490 -2.918305 -2.979692   -4.042347 -3.448734   -3.189924

cg17505339  3.082191  3.924931    4.163206  3.255373    3.654134

cg11954957  1.546401  1.912204    1.727910  2.441267    1.618331

  There is a typo (extra whitespace) in the BiocViews URLI was unable to get the Gviz plot to correctly render. Unsure what\'s going on here as the Gviz version on my machine matches that in the workflow (v1.16.1) \> plotTracks(tracks, from=minbase, to=maxbase, showTitle=TRUE, add53=TRUE,

+            add35=TRUE, grid=TRUE, lty.grid=3, sizes=sizes, length(tracks))

Error in valid.viewport(x, y, width, height, just, gp, clip, xscale, yscale,  :

  invalid \'yscale\' in viewport

In addition: Warning messages:

1: In min(x) : no non-missing arguments to min; returning Inf

2: In max(x) : no non-missing arguments to max; returning -Inf

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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As someone who has experience with R/Bioconductor and with genomics data, but not direct experience analyzing methylation array data, I found the workflow very useful and I would suggest it to anyone wanting to start analyzing this type of data.

I do agree with the other reviewers that the value of the workflow will be greatly increased if the dataset used was available as an R object. The authors should consider submitting an experiment data package to Bioconductor to accompany the workflow. Alternatively, they could provide the dataset as a supplementary file.

As for the analysis itself, I only have one major question. Note that I do not have direct experience analyzing methylation array, so this is a genuine question rather than a criticism.

In gene expression analysis, we tend to perform filtering prior to normalization, while the authors here first normalize the data by quantile normalization and then filter out probes that are low quality and/or affected by SNPs. Wouldn\'t it be safer to perform filtering before normalization? I understand that given the few probes affected, the order has likely very little effect in this dataset. But I naively imagine that if there are many problematic probes and, say, the quality of the samples is confounded with the biology, there could be issues in using low quality probes for normalization.

Other minor points: I agree that the code should be re-run with the latest release of R and Bioconductor.In the definition of \\beta, \\alpha should be defined, and its default value in getBeta() should be specified.Spelling: most of the article uses British English spelling, but the word \"normalization\" is sometimes (but not always) spelled in American English.A sentence describing what is the procedure implemented in preprocessQuantile() is needed for people not familiar with normalization.I agree that it would be useful to provide a brief description of what is a contrasts matrix as this section could be confusing for people unfamiliar with statistical models.For the same reason, the authors should add a brief explanation of the problem of multiple testing and what is the false discovery rate. Or at least provide references to the appropriate literature.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Maksimovic

Jovana

Murdoch Childrens Research Institute, Australia
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Thanks for your review, Davide. 

While we agree that normalisation post-filtering makes sense, there are some practical aspects with the data objects that minfi uses which makes this difficult. Many (but not all) normalisation procedures in minfi accept an rgSet object, which can be thought of as a raw data object, which cannot easily be subset by CpG site. These normalisation procedures then output a different type of data object, such as MethylSet or GenomicRatioSet, which are much easier to work with in terms of filtering out problematic CpG sites. Due to the sheer number of CpG sites observed per sample (\>450,000) we believe it shouldn't make too much difference for most datasets, especially if very poor quality samples are excluded prior to normalisation, although it is possible that there are exceptions to this.

Response to minor points: We have spent some time modifying the workflow to run with the latest R and Bioconductor.We have added additional details regarding beta values, M-values and the offset in the paper. We have changed \"normalization\" to \"normalisation\" throughout the text.A sentence has been added about preprocessQuantile in the normalisation section. We have included some additional explanation of contrast matrices. An additional paragraph was added explaining about the issues of multiple testing in very high dimensional data.
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I am not an expert in analysis of methylation data, and have not used the methylation packages mentioned in this workflow, so I reviewed the workflow as an uninitiated reader might approach it.

Major comments:

I found the workflow to be easy to follow and informative. The authors have done a good job summarizing a large and complex topic into an reasonable size for a workflow article, while still mentioning the various alternatives that are possible at each step. I appreciated the focus on EDA and checking the quality of results by eye, for example the M-values for the most significant tests and the MDS plots colored by different variables.

I did not try to run the code, and I agree with the other two reviewers that the code and datasets should be made available and linked to from this workflow.

Minor comments:

The first time "moderated t-statistics" is mentioned, it would benefit to have a citation so that a reader who hasn't encountered this method before can read the reference, e.g. Smyth 2004.

The first or second time IDAT files are mentioned, a small description of these would be useful, a little more than just that these are the raw files. Which platforms produce IDAT files? Are they compressed files? About how large are they?

Figure 2: It wasn't obvious at first that the plot on the right is the same as the left but zoomed in.

When discussing the choice of normalization depending on whether or not there are global changes across samples due to underlying biology, the authors might consider referencing the *quantro* article and Bioconductor package by Stephanie Hicks for determining whether there are global changes in genomic datasets across samples, and therefore whether quantile normalization is appropriate. Hicks has an example of whether or not to use quantile normalization for methylation data in the article. <https://www.bioconductor.org/packages/quantro> Principal components is misspelled in the text: "principle components"

In the paragraph above the call to *makeContrasts*, it would be good to state in the text in one sentence what it is this function does, for the benefit of someone who has never performed linear modeling before. Likewise, to explicitly state that coef=1 is referencing the first column of the contrast matrix. It should be stated what is the B-statistic which orders the topTable.

The authors should explain a bit more what is being shown in Figure 10 in the caption.

In the text and code the authors have written DNAseI, but I believe the more common capitalization is DNaseI.

The authors might consider commenting on the top GO categories and the associated FDR values. How far down the list should one look? Can the authors advise the reader how GO results should be reported? Is it fair to pick out the most relevant categories from this list and only report them?

It wasn't clear to me the difference between the *gometh* and *gsameth* approaches.

It would be good to provide references to literature for "it has been hypothesised that highly variable CpGs in cancer are important for tumour progression".

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Maksimovic

Jovana

Murdoch Childrens Research Institute, Australia

**Competing interests:**No competing interests were disclosed.
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Thank you for reviewing our paper, Michael.

In response to your comments/suggestions we have made the following changes: The Smyth 2004 citations have been added the first time "moderated t-statistics" is mentionedA description of IDAT files has been added to the text along with a reference to a Bioconductor package that is specifically for reading IDAT files.We have added to the legend for Figure 2 to clarify that the plot on the right is the same as the left but zoomed in.There is now a reference to Hicks and quantro in included in the Normalisation section.Spelling mistakes and typos have been fixed.Function of *makeContrasts* is described: See response to Davide Risso.We now explicitly state that coef=1 is referencing the first column of the contrast matrix.Included explanation for B-statistic and citation.More detail about the plot has been added to the figure caption for Figure 10.Changed DNAseI to DNaselTypically we would consider GO categories that have associated FDRs less than 5% as significant. Some discussion of these points has been added to the gene set testing section.The gometh function specifically tests only GO and KEGG pathways, whereas the gsameth is a more general function that requires the user to supply their own gene sets for testing.We have changed the sentence "it has been hypothesised that highly variable CpGs in cancer are important for tumour progression" to "it has been hypothesised that highly variable CpGs in cancer may contribute to tumour heterogeneity" and included the following reference:Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, Briem E, Zhang K, Irizarry RA, Feinberg AP: Increased methylation variation in epigenetic domains across cancer types. Nat Genet. 2011, 43: 768-775
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This paper is a well-written workflow for analysing DNA methylation microarrays using Bioconductor packages. A challenge in writing these workflows is to produce something that is opinionated enough to be useful and balanced enough to be fair to packages developed by other people; I believe the authors have struck the right balance.

However, my overall assessment is \"Approved With Reservations\" because the data used in the workflow is not easily available and therefore the workflow cannot be tested out by the interested reader.

I spent some time trying to compile the raw data from GEO, but to me this feels a bit too much to expect of the reader, especially when it is likely that the interested reader is a beginner or intermediate user of bioinformatics software. I strongly believe the workflow should either include code to curate/construct/download the necessary files such as SampleSheet.csv and the IDAT files or include a link to prepared example data that can be used right from the \'Loading the data\' section of the workflow. For example, <http://f1000research.com/articles/4-1070/v1> uses data from the *airway* Bioconductor package that can easily be installed by the reader to follow along with the workflow.

My other main suggestion would be to re-run the code using the recently published Bioconductor version 3.3. I expect this might require some minor changes to the code, e.g., the minfi::read.450k\* functions have been deprecated in favour of minfi::read.metharray\* functions.

I have some additional minor comments and suggestions that I will include once I\'m able to run through and review the workflow from beginning to end.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Hickey

Peter

Johns Hopkins Bloomberg School of Public Health, USA

**Competing interests:**No competing interests were disclosed.
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p2: beta = M / (M + U + alpha), the alpha parameter should be explained. Also, both the definition of beta and Mvalue differ slightly from that given in the cited Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11, 587 (2010).p3: Perhaps worth mentioning that a complete list of packages for analysing DNA methylation data can be accessed using BiocViews (https://www.bioconductor.org/packages/release/bioc/html/biocViews.html and https://www.bioconductor.org/packages/release/BiocViews.html\#\_\_\_DNAMethylation)p4: \"\...loading all the package libraries\...\" should be \"\...loading all the packages\...\"p4: Perhaps worth commenting on which of the loaded packages are methylation-focused and/or purpose of other packages, e.g., stringr, Gviz.p4: This is \*super\* pedantic (sorry!): strictly speaking the IlluminaHumanMethylation450kmanifest package provides the Illumina manifest for the 450k array, which can then be accessed by using \`minfi::getAnnotation()\`Figure 2: Not immediately obvious that righthand plot is zoomed in version of lefthand plot. The caption could better explain this.p10: The code produces a warning. Would be helpful to the reader to comment on whether this is cause for concern in this case.Figure 9: Wondering whether helpful to have each panel with y-axis = \[0, 1\]p25: \`islandData\` apparently contains 0 ranges. This looks like a bug in the code.p28: \"For gene ontology testing (default), the user can specific collection = \"GO\" for KEGG testing collection = \"KEGG\"\"; this sentence seems incomplete or is perhaps missing a wordp29 and p30: The code produces a warning. Would be helpful to the reader to comment on whether this is cause for concern in this case.The workflow uses multiple packages and it\'s not always clear where each function comes from. This could be clarified e.g., by namespacing functions such as \`limma::plotMDS()\` instead of \`plotMDS()\`
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Thanks for taking the time to review our workflow, Peter.

In response to your suggestion we have made the data available and rerun the workflow using the latest R and Bioconductor.

In response to your other comments:  p2: beta = M / (M + U + alpha), the alpha parameter should be explained. Also, both the definition of beta and Mvalue differ slightly from that given in the cited Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11, 587 (2010).*This has been addressed. See response to Davide Risso.*p3: Perhaps worth mentioning that a complete list of packages for analysing DNA methylation data can be accessed using BiocViews (https://www.bioconductor.org/packages/release/bioc/html/biocViews.html and https://www.bioconductor.org/packages/release/BiocViews.html\#\_\_\_DNAMethylation)*This has been added to the paper.*p4: \"\...loading all the package libraries\...\" should be \"\...loading all the packages\...\"*The text has been modified accordingly.*p4: Perhaps worth commenting on which of the loaded packages are methylation-focused and/or purpose of other packages, e.g., stringr, Gviz.*The text has been modified accordingly.*p4: This is \*super\* pedantic (sorry!): strictly speaking the IlluminaHumanMethylation450kmanifest package provides the Illumina manifest for the 450k array, which can then be accessed by using \`minfi::getAnnotation()\`*The text has been modified accordingly.*Figure 2: Not immediately obvious that righthand plot is zoomed in version of lefthand plot. The caption could better explain this.*This has been clarified in the figure caption.*p10: The code produces a warning. Would be helpful to the reader to comment on whether this is cause for concern in this case.*A sentence has been included that explains the reason for the waring.*Figure 9: Wondering whether helpful to have each panel with y-axis = \[0, 1\]*As we are trying to highlight the differences between the groups tested for **individual** CpGs and not comparing between CpGs, we feel that the axes are appropriate for the purposes of \"sanity checking\" the results of the statistical analysis.*p25: \`islandData\` apparently contains 0 ranges. This looks like a bug in the code.*This was due to the fact that there were not any CpG islands present in the region being plotted; we have selected another region to plot that does have a CpG island so that islandData is no longer empty.*p28: \"For gene ontology testing (default), the user can specific collection = \"GO\" for KEGG testing collection = \"KEGG\"\"; this sentence seems incomplete or is perhaps missing a word*This sentence has been modified.*p29 and p30: The code produces a warning. Would be helpful to the reader to comment on whether this is cause for concern in this case.*Added a sentence to the text to explain the warning.*The workflow uses multiple packages and it\'s not always clear where each function comes from. This could be clarified e.g., by namespacing functions such as \`limma::plotMDS()\` instead of \`plotMDS()\`*We don't feel it is a particularly useful exercise to change every function to include the package name. Searching the help for any of the functions will inform users which package the function comes from. For example ?plotMDS.*
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This paper describes a workflow for processing, filtering and analysis of Illumina Infinium methylation array data. It showcases a reproducible pipeline integrating a suite of tools from Bioconductor for multi-faceted genomic insights. While none of the tools individually are novel, their integration into a sensible, reproducible pipeline is. I am recommending this manuscript for indexationfor 3 main reasons: The tools contained therein and their application are in line with, or near, best practice. The workflow itself contains all the major steps that this reviewer usually uses for their methylation array processing.An integrated workflow such as this will be valuable for novice and intermediate bioinformaticians who are tasked with processing methylation data. The number of caveats and sanity checks needed for appropriate biological interpretation is not trivial, and this workflow does a satisfactory job of outlining them.The reproducible nature of this manuscript is a strength; it is very \"coalface bioinformatics\". Many published methods have very poor or buggy implementations and no effort is made to contextualise them in a given pipeline. Publication may set a precedent for other authors to give worked examples and context, which in this reviewer\'s opinion accelerates the path to best practice.

Minor amendments needed: I could not find any public links to the data files imported into this workflow. These ought to be provided.a) The mathematical definition of  *β* is given as  *β = M/(M +U + α)*. While I realise *α* is a fudge factor for offset purposes this is not clear to the lay reader and needs to be made so.b) Why are there no offsets for  *M* or  *U*in the calculation of  *M *values, especially since there is one for the calculation of *β*? On (admittedly) rare occasions  *M* or  *U *will be exactly zero and hence offsets need to be put in both the numerator and denominator of the ratio to be log-transformed, else a non-number will result.A justification for the preference of  *M* values over  *β *values for use in the MDS plots is needed, especially since the statement is made that \"Beta values are generally preferable \... for graphical presentation\". This reviewer\'s experience is that  *β *is much more common for use in PCA/MDS, and is certainly the standard for other methylation platforms e.g. bisulfite sequencing data.Legends are needed for density plots in Figs. 3 and 8. I appreciate  *minfi* annoyingly puts the default legend in the top right, obscuring the hypermethylated mode, but a custom call to legend() ought to fix this.Appropriate Y-axis labels are needed for Figs. 9 and 14.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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Thanks Tim for taking the time to review our paper.

In response to your comments/suggestions: I could not find any public links to the data files imported into this workflow. These ought to be provided.*In addition to the references, we have now included links to GEO for the data used and have also made a bundle of all the data available on Figshare which can now be used directly from within R to download the data and complete the workflow. *a) The mathematical definition of  *β* is given as  *β = M/(M +U + α)*. While I realise  *α* is a fudge factor for offset purposes this is not clear to the lay reader and needs to be made so.b) Why are there no offsets for  *M* or  *U *in the calculation of  *M *values, especially since there is one for the calculation of  *β*? On (admittedly) rare occasions  *M* or  *U *will be exactly zero and hence offsets need to be put in both the numerator and denominator of the ratio to be log-transformed, else a non-number will result.*This has been clarified in the text. See also response to Davide Risso.*A justification for the preference of  *M* values over  *β *values for use in the MDS plots is needed, especially since the statement is made that \"Beta values are generally preferable \... for graphical presentation\". This reviewer\'s experience is that  *β *is much more common for use in PCA/MDS, and is certainly the standard for other methylation platforms e.g. bisulfite sequencing data.*We disagree that beta values should be used in principal components analysis. While plotMDS does produce a graphic, the function is performing a statistical analysis (i.e. principal components analysis), which is based on normal distribution theory. The same reasons for not performing differential methylation analysis on the beta values apply in this case (i.e. heteroscedasticity of the beta values).  *Legends are needed for density plots in Figs. 3 and 8. I appreciate  *minfi* annoyingly puts the default legend in the top right, obscuring the hypermethylated mode, but a custom call to legend() ought to fix this.*These legends have been added as suggested.*Appropriate Y-axis labels are needed for Figs. 9 and 14.*The Y-axis labels have been added.*
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